KIMCO REALTY CORPORATION (a Maryland corporation) Debt Securities UNDERWRITING AGREEMENT
Exhibit 1.1
KIMCO REALTY CORPORATION
(a Maryland corporation)
(a Maryland corporation)
Debt Securities
April 23, 0000
XXXX XX XXXXXXX SECURITIES LLC
CITIGROUP GLOBAL MARKETS INC.
X.X. XXXXXX SECURITIES INC.
UBS SECURITIES LLC
CITIGROUP GLOBAL MARKETS INC.
X.X. XXXXXX SECURITIES INC.
UBS SECURITIES LLC
c/o Banc of America Securities LLC
Hearst Tower
000 Xxxxx Xxxxx Xxxxxx
Xxxxxxxxx, Xxxxx Xxxxxxxx 00000
Hearst Tower
000 Xxxxx Xxxxx Xxxxxx
Xxxxxxxxx, Xxxxx Xxxxxxxx 00000
Ladies and Gentlemen:
Kimco Realty Corporation, a Maryland corporation (the “Company”), proposes to issue and sell
its unsecured senior debt securities (the “Securities”), from time to time, in one or more
offerings on terms to be determined at the time of sale. The Securities will be issued under an
indenture, dated as of September 1, 1993, as amended by the First Supplemental Indenture dated as
of August 4, 1994, the Second Supplemental Indenture dated as of April 7, 1995, the Third
Supplemental Indenture dated as of June 2, 2006, the Fourth Supplemental Indenture to be dated as
of April 26, 2007 and as further amended or supplemented from time to time (the “Indenture”),
between the Company and Bank of New York, as trustee (the “Trustee”). The Indenture has been
qualified under the Trust Indenture Act of 1939, as amended (the “1939 Act”), and the rules and
regulations of the Securities and Exchange Commission (the “Commission”) under the 1939 Act (the
“1939 Regulations”). Each series of Securities may vary, as applicable, as to aggregate principal
amount, maturity date, interest rate or formula and timing of payments thereof, redemption and/or
repayment provisions, conversion provisions, sinking fund requirements, if any, and any other
variable terms which the Indenture contemplates may be set forth in the Securities as issued from
time to time. As used herein, “you” and “your”, unless the context otherwise requires, shall mean
the parties to whom this Agreement is addressed together with the other parties, if any, identified
in the applicable Terms Agreement (as hereinafter defined) as additional co-managers with respect
to Underwritten Securities (as hereinafter defined) purchased pursuant thereto.
Whenever the Company determines to make an offering of Securities through you or through an
underwriting syndicate managed by you, the Company will enter into an agreement (the “Terms
Agreement”) providing for the sale of such Securities (the “Underwritten
Securities”) to, and the purchase and offering thereof by, you and such other underwriters, if
any, selected by you as have authorized you to enter into such Terms Agreement on their behalf (the
“Underwriters”, which term shall include you whether acting alone in the sale of the Underwritten
Securities or as a member of an underwriting syndicate and any Underwriter substituted pursuant to
Section 10 hereof). The Terms Agreement relating to the offering of Underwritten Securities shall
specify the principal amount of Underwritten Securities to be initially issued (the “Initial
Underwritten Securities”), the names of the Underwriters participating in such offering (subject to
substitution as provided in Section 10 hereof), the principal amount of Initial Underwritten
Securities which each such Underwriter severally agrees to purchase, the names of such of you or
such other Underwriters acting as co-managers, if any, in connection with such offering, the price
at which the Initial Underwritten Securities are to be purchased by the Underwriters from the
Company, the initial public offering price, if any, of the Initial Underwritten Securities, the
Applicable Time (as defined below), any and all Issuer General Use Free Writing Prospectuses (as
defined below), the time, date and place of delivery and payment, any delayed delivery arrangements
and any other variable terms of the Initial Underwritten Securities (including, but not limited to,
current ratings, designations, denominations, interest rates or formulas, interest payment dates,
maturity dates, conversion provisions, redemption and/or repayment provisions and sinking fund
requirements applicable to the Initial Underwritten Securities). In addition, each Terms Agreement
shall specify whether the Company has agreed to grant to the Underwriters an option to purchase
additional Underwritten Securities to cover over-allotments, if any, and the aggregate principal
amount of Underwritten Securities subject to such option (the “Option Securities”). As used
herein, the term “Underwritten Securities” shall include the Initial Underwritten Securities and
all or any portion of the Option Securities agreed to be purchased by the Underwriters as provided
herein, if any. The Terms Agreement, which shall be substantially in the form of Exhibit A hereto,
may take the form of an exchange of any standard form of written telecommunication between you and
the Company. Each offering of Underwritten Securities through you or through an underwriting
syndicate managed by you will be governed by this Agreement, as supplemented by the applicable
Terms Agreement.
The Company has filed with the Commission an automatic shelf registration statement on Form
S-3 (No. 333-133908), including the related base prospectus, which registration statement became
effective upon filing under Rule 462(e) of the rules and regulations of the Commission (the “1933
Act Regulations”) under the Securities Act of 1933, as amended (the “1933 Act”). Such registration
statement covers the registration of the Securities under the 1933 Act. Promptly after execution
and delivery of the applicable Terms Agreement, the Company will prepare and file a prospectus
supplement relating to the Underwritten Securities in accordance with the provisions of Rule 430B
(“Rule 430B”) of the 1933 Act Regulations and paragraph (b) of Rule 424 (“Rule 424(b)”) of the 1933
Act Regulations. Any information included in such prospectus supplement that was omitted from such
registration statement at the time it became effective but that is deemed to be part of and
included in such registration statement pursuant to Rule 430B is referred to as “Rule 430B
Information.” Each prospectus, if any, used in connection with the offering of the Underwritten
Securities that omitted Rule 430B Information, together with the documents incorporated by
reference therein pursuant to Item 12 of Form S-3 under the 1933 Act, is herein called a
“preliminary prospectus.” Such registration statement, at each time of effectiveness under the
1933 Act and the 1933 Act Regulations prior to the execution of the applicable Terms Agreement,
including the amendments thereto to such time, the exhibits and
2
any schedules thereto at such time, the documents incorporated by reference therein pursuant
to Item 12 of Form S-3 under the 1933 Act at such time and the documents otherwise deemed to be a
part thereof or included therein by the 1933 Act Regulations, is herein called the “Registration
Statement”; provided, however, that the term “Registration Statement” shall be deemed to include
information contained in the final prospectus supplement relating to the Underwritten Securities
that is retroactively deemed to be a part of such registration statement (as amended) as of the
time specified in Rule 430B of the 1933 Act Regulations. The Registration Statement at the time it
originally became effective is herein called the “Original Registration Statement.” The base
prospectus and final prospectus supplement, in the form first furnished or made available to the
Underwriters for use in connection with the offering of the Underwritten Securities, including the
documents incorporated by reference therein pursuant to Item 12 of Form S-3 under the 1933 Act at
the time of the execution of the applicable Terms Agreement, is herein called the “Prospectus.”
For purposes of this Agreement, all references to the Registration Statement, any preliminary
prospectus or the Prospectus or any amendment or supplement to any of the foregoing shall be deemed
to include the copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis
and Retrieval system (“XXXXX”).
All references in this Agreement to financial statements and schedules and other information
which is “contained,” “included” or “stated” (or other references of like import) in the
Registration Statement, any preliminary prospectus or the Prospectus or any amendment or supplement
thereto shall be deemed to include all such financial statements and schedules and other
information which is or is deemed to be incorporated by reference in or otherwise deemed by the
1933 Act Regulations to be a part of or included in the Registration Statement, any preliminary
prospectus or the Prospectus, as the case may be, and all references in this Agreement to
amendments or supplements to the Registration Statement, any preliminary prospectus or the
Prospectus shall be deemed to include the filing of any document under the Securities Exchange Act
of 1934, as amended (the “1934 Act”), which is or is deemed to be incorporated by reference in or
otherwise deemed by the 1933 Act Regulations to be a part of or included in the Registration
Statement, such preliminary prospectus or the Prospectus, as the case may be, after the most recent
effective date prior to the execution of the applicable Terms Agreement, in the case of the
Registration Statement, or the respective dates of the Prospectus or any preliminary prospectus, in
the case of the Prospectus and any preliminary prospectus.
Section 1. Representations and Warranties.
(a) The Company represents and warrants to you, as of the date hereof, and to you and each
other Underwriter named in the applicable Terms Agreement, as of the date thereof, as of the
Closing Time referred to in Section 2(c) hereof and, if applicable, as of each Date of Delivery
referred to in Section 2(b) hereof (in each case, a “Representation Date”), and agrees with each
Underwriter, as follows:
(i) (A) At the time of filing the Original Registration Statement, (B) at the
time of the most recent amendment thereto for the purposes of complying with Section
10(a)(3) of the 1933 Act (whether such amendment was by post-effective amendment,
incorporated report filed pursuant to Section 13 or 15(d) of the 1934 Act or form of
prospectus), (C) at the time the Company or any person acting on
3
its behalf (within the meaning, for this clause only, of Rule 163(c) of the 1933
Act Regulations) made any offer relating to the Underwritten Securities in reliance
on the exemption of Rule 163 of the 1933 Act Regulations (“Rule 163”) and (D) as of
the date of the execution and delivery of this Agreement and the applicable Terms
Agreement (the “Execution Date”), the Company was and is a “well-known seasoned
issuer,” as defined in Rule 405 of the 1933 Act Regulations (“Rule 405”). The
Registration Statement is an “automatic shelf registration statement,” as defined in
Rule 405. The Company is and remains eligible to use the automatic shelf
registration form and the Securities, since their registration on the Registration
Statement, have been and remain eligible for registration by the Company on a Rule
405 “automatic shelf registration statement.” The Company has not received from the
Commission any notice pursuant to Rule 401(g)(2) of the 1933 Act Regulations
objecting to the use of the automatic shelf registration statement form.
At the time of filing the Original Registration Statement, at the earliest time
thereafter that the Company or another offering participant (after being engaged by
the Company in connection therewith) made a bona fide offer (within the meaning of
Rule 164(h)(2) of the 1933 Act Regulations) of the Underwritten Securities and as of
the Execution Date, the Company was not and is not an “ineligible issuer,” as
defined in Rule 405.
(ii) The Original Registration Statement became effective upon filing under Rule
462(e) of the 1933 Act Regulations (“Rule 462(e)”) on May 9, 2006, and any
post-effective amendment thereto also became effective upon filing under Rule 462(e).
No stop order suspending the effectiveness of the Registration Statement has been
issued under the 1933 Act and no proceedings for that purpose have been instituted or
are pending or, to the knowledge of the Company, are contemplated by the Commission,
and any request on the part of the Commission for additional information has been
complied with.
Any offer that is a written communication relating to the Underwritten
Securities made prior to the filing of the Original Registration Statement by the
Company or any person acting on its behalf (within the meaning, for this paragraph
only, of Rule 163(c) of the 1933 Act Regulations) has been filed with the Commission
in accordance with the exemption provided by Rule 163 and otherwise complied with
the requirements of Rule 163, including without limitation the legending
requirement, to qualify such offer for the exemption from Section 5(c) of the 1933
Act provided by Rule 163.
At the respective times the Original Registration Statement and each amendment
thereto became effective and at each deemed effective date with respect to the
Underwriters pursuant to Rule 430B(f)(2) of the 1933 Act Regulations, the
Registration Statement complied, complies and will comply in all material respects
with the requirements of the 1933 Act and the 1933 Act Regulations and the 1939 Act
and the 1939 Act Regulations, and did not, does not and will not contain an untrue
statement of a material fact or omit to state a
4
material fact required to be stated therein or necessary to make the statements
therein not misleading.
The Prospectus and each amendment or supplement thereto, if any, at the time
the Prospectus or any such amendment or supplement is issued and at the Closing Time
and at each Date of Delivery, if any, complied, complies and will comply in all
material respects with the requirements of the 1933 Act and the 1933 Act
Regulations, and neither the Prospectus nor any amendment or supplement thereto
included, includes or will include an untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements therein, in the
light of the circumstances under which they are made, not misleading.
Each preliminary prospectus (including the base prospectus filed as part of the
Original Registration Statement or any amendment thereto) complied when so filed in
all material respects with the 1933 Act Regulations and each preliminary prospectus
and the Prospectus delivered or made available to the Underwriters for use in
connection with each offering of Underwritten Securities was and will, at the time
of such delivery, be identical to the electronically transmitted copies thereof
filed with the Commission pursuant to XXXXX, except to the extent permitted by
Regulation S-T.
As of the Applicable Time, neither (x) the Issuer General Use Free Writing
Prospectus(es) (as defined below) (including the Final Term Sheet (as defined in
Section 3(b))) issued at or prior to the Applicable Time or any preliminary
prospectus relating to the Underwritten Securities delivered or made available to
the Underwriters prior to the Execution Date, all considered together (collectively,
the “General Disclosure Package”), nor (y) any individual Issuer Limited Use Free
Writing Prospectus, when considered together with the General Disclosure Package,
included any untrue statement of a material fact or omitted to state any material
fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading.
As used in this subsection and elsewhere in this Agreement:
“Applicable Time” means such time and date as indicated in the applicable Terms
Agreement.
“Issuer Free Writing Prospectus” means any “issuer free writing prospectus,” as
defined in Rule 433 of the 1933 Act Regulations (“Rule 433”), relating to the
Underwritten Securities that (i) is required to be filed with the Commission by the
Company, (ii) is a “road show that is a written communication” within the meaning of
Rule 433(d)(8)(i), whether or not required to be filed with the Commission or (iii)
is exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a
description of the Underwritten Securities or of the offering thereof that does not
reflect the final terms, in each case in the form
5
filed or required to be filed with the Commission or, if not required to be filed,
in the form retained in the Company’s records pursuant to Rule 433(g).
“Issuer General Use Free Writing Prospectus” means any Issuer Free Writing
Prospectus that is intended for general distribution to prospective investors, as
evidenced by its being specified in Schedule A to the applicable Terms Agreement,
and the Final Term Sheet.
“Issuer Limited Use Free Writing Prospectus” means any Issuer Free Writing
Prospectus that is not an Issuer General Use Free Writing Prospectus.
Each Issuer Free Writing Prospectus, as of its issue date and at all subsequent
times through the completion of the public offer and sale of the Underwritten
Securities (which completion you shall promptly communicate to the Company) or until
any earlier date that the Company notified or notifies you as described in Section
3(e), did not, does not and will not include any information that conflicted,
conflicts or will conflict with the information contained in the Registration
Statement or the Prospectus.
The representations and warranties in this subsection shall not apply to
statements in or omissions from the Registration Statement, the Prospectus or any
Issuer Free Writing Prospectus made in reliance upon and in conformity with written
information furnished to the Company by any Underwriter through you expressly for
use therein.
(iii) The documents incorporated or deemed to be incorporated by reference in
the Registration Statement, any preliminary prospectus or the Prospectus, at the time
they were or hereafter are filed with the Commission, complied and will comply in all
material respects with the requirements of the 1934 Act and the rules and regulations
of the Commission thereunder (the “1934 Act Regulations”), and, when read together
with the other information in the Registration Statement, any preliminary prospectus
or the Prospectus, as the case may be, (a) at the time the Original Registration
Statement became effective, (b) at the earlier of the time the Prospectus was first
used and the date and time of the first contract of sale of Underwritten Securities
and (c) at each Representation Date, did not and will not include an untrue statement
of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading.
(iv) The accountants who certified the financial statements, financial statement
schedules and historical summaries of revenue and certain operating expenses for the
properties related thereto included or incorporated by reference in the Registration
Statement, the General Disclosure Package or the Prospectus are independent public
accountants as required by the 1933 Act and the 1933 Act Regulations.
6
(v) The historical financial statements included or incorporated by reference in
the Registration Statement, the General Disclosure Package or the Prospectus present
fairly the financial position of the Company and its consolidated subsidiaries as at
the dates indicated and the results of their operations for the periods specified;
except as may otherwise be stated in the Registration Statement, the General
Disclosure Package and the Prospectus, said financial statements have been prepared
in conformity with generally accepted accounting principles applied on a consistent
basis throughout the periods involved; and the financial statement schedules and
other financial information and data included or incorporated by reference in the
Registration Statement, the General Disclosure Package or the Prospectus present
fairly the information required to be stated therein.
(vi) The historical summaries of revenue and certain operating expenses included
or incorporated by reference in the Registration Statement, the General Disclosure
Package or the Prospectus, if any, present fairly the revenue and those operating
expenses included in such summaries for the periods specified in conformity with
generally accepted accounting principles; the pro forma financial statements included
or incorporated by reference in the Registration Statement, the General Disclosure
Package or the Prospectus, if any, present fairly the pro forma financial position of
the Company and its consolidated subsidiaries as at the dates indicated and the pro
forma results of their operations for the periods specified; and the pro forma
financial statements, if any, have been prepared in conformity with generally
accepted accounting principles applied on a consistent basis, the assumptions on
which such pro forma financial statements have been prepared are reasonable and are
set forth in the notes thereto, such pro forma financial statements have been
prepared, and the pro forma adjustments set forth therein have been applied, in
accordance with the applicable accounting requirements of the 1933 Act and the 1933
Act Regulations, and such pro forma adjustments have been properly applied to the
historical amounts in the compilation of such statements; other than as set forth
therein, the Company is not required to include any financial statements pursuant to
Rule 3-05 or Rule 3-14 or pro forma financial statements in the Registration
Statement, the General Disclosure Package or the Prospectus under the 1933 Act or the
1933 Act Regulations or under the 1934 Act or the 1934 Act Regulations; and all
disclosures contained in the Registration Statement, the General Disclosure Package
or the Prospectus, if any, regarding “non-GAAP financial measures” (as such term is
defined by the rules and regulations of the Commission) comply with Regulation G
under the 1934 Act and Item 10 of Regulation S-K of the 1933 Act Regulations, to the
extent applicable.
(vii) Since the respective dates as of which information is given in the
Registration Statement, the General Disclosure Package or the Prospectus, except as
may otherwise be stated therein or contemplated thereby, (A) there has been no
material adverse change in the condition, financial or otherwise, or in the earnings,
business affairs or business prospects of the Company and its subsidiaries considered
as one enterprise, whether or not arising in the ordinary course of
7
business, (B) there have been no transactions or acquisitions entered into by
the Company or any of its subsidiaries other than those in the ordinary course of
business, which are material with respect to the Company and its subsidiaries
considered as one enterprise, and (C) except for regular quarterly dividends on the
Company’s common stock, par value $.01 per share (the “Common Stock”), or dividends
declared, paid or made in accordance with the terms of any series of the Company’s
preferred stock (the “Preferred Stock”), there has been no dividend or distribution
of any kind declared, paid or made by the Company on any class of its capital stock.
(viii) The Company has been duly incorporated and is validly existing as a
corporation under the laws of Maryland and is in good standing with the State
Department of Assessments and Taxation of Maryland with corporate power and authority
to own, lease and operate its properties and to conduct its business as described in
the Prospectus and the General Disclosure Package; and the Company is duly qualified
as a foreign corporation to transact business and is in good standing in each
jurisdiction in which such qualification is required, whether by reason of the
ownership or leasing of property or the conduct of business, except where the failure
to so qualify would not have a material adverse effect on the condition, financial or
otherwise, or the earnings, business affairs or business prospects of the Company and
its subsidiaries considered as one enterprise.
(ix) Each significant subsidiary (as defined in Rule 1-02 of Regulation S-X
promulgated under the 0000 Xxx) of the Company (each, a “Significant Subsidiary”) has
been duly incorporated and is validly existing as a corporation in good standing
under the laws of the jurisdiction of its incorporation, has corporate power and
authority to own, lease and operate its properties and to conduct its business as
described in the Prospectus and the General Disclosure Package and is duly qualified
as a foreign corporation to transact business and is in good standing in each
jurisdiction in which such qualification is required, whether by reason of the
ownership or leasing of property or the conduct of business, except where the failure
to so qualify would not have a material adverse effect on the condition, financial or
otherwise, or the earnings, business affairs or business prospects of the Company and
its subsidiaries considered as one enterprise; and all of the issued and outstanding
capital stock of each Significant Subsidiary has been duly authorized and validly
issued, is fully paid and non-assessable and is owned by the Company, directly or
through subsidiaries, free and clear of any security interest, mortgage, pledge,
lien, encumbrance, claim or equity, except for security interests granted in respect
of indebtedness of the Company or any of its subsidiaries and referred to in the
Prospectus and the General Disclosure Package.
(x) The Indenture has been duly and validly authorized, executed and delivered
by the Company and constitutes the valid and legally binding agreement of the
Company, enforceable in accordance with its terms, except as enforcement thereof may
be limited by bankruptcy, insolvency or other similar laws relating to or affecting
enforcement of creditors’ rights generally or by general equity princi-
8
ples (regardless of whether enforcement is considered in a proceeding in equity
or at law); and the Indenture has been duly qualified under the 0000 Xxx.
(xi) The authorized, issued and outstanding capital stock of the Company is as
set forth in the Prospectus and the General Disclosure Package under “Description of
Common Stock” and “Description of Preferred Stock” (except for subsequent issuances,
if any, pursuant to reservations, agreements, employee benefit plans, dividend
reinvestment plans, employee and director stock option plans referred to in the
Prospectus and the General Disclosure Package or the exercise of convertible
securities referred to in the Prospectus and the General Disclosure Package); and the
outstanding capital stock of the Company has been duly authorized and validly issued
and is fully paid and non-assessable and is not subject to preemptive or other
similar rights.
(xii) The Underwritten Securities being sold pursuant to the applicable Terms
Agreement have been duly authorized by the Company for issuance and sale pursuant to
this Agreement and, when issued, authenticated and delivered pursuant to the
provisions of the Indenture, against payment of the consideration therefor specified
in the applicable Terms Agreement or any Delayed Delivery Contract (as hereinafter
defined), the Underwritten Securities will constitute valid and legally binding
obligations of the Company, enforceable in accordance with their terms, except as
enforcement thereof may be limited by bankruptcy, insolvency (including, without
limitation, all laws relating to fraudulent transfers), reorganization, moratorium or
similar laws affecting enforcement of creditors’ rights generally or by general
equity principles (regardless of whether enforcement is considered in a proceeding in
equity or at law); the Underwritten Securities and the Indenture conform in all
material respects to the respective statements relating thereto contained in the
Registration Statement, the Prospectus and the General Disclosure Package and will be
in substantially the respective forms filed or incorporated by reference, as the case
may be, as exhibits to the Registration Statement; and the Underwritten Securities
will be entitled to the benefits provided by the Indenture.
(xiii) If applicable, the Common Stock or Preferred Stock issuable upon
conversion of any of the Underwritten Securities have been duly and validly
authorized and reserved for issuance upon such conversion by all necessary corporate
action and such shares, when issued upon such conversion, will be duly and validly
issued and will be fully paid and non-assessable, and the issuance of such shares
upon such conversion will not be subject to preemptive or other similar rights; and
the shares of Common Stock or Preferred Stock so issuable will conform in all
material respects, as of the applicable Representation Date, to all statements
relating thereto contained in the Registration Statement, the Prospectus and the
General Disclosure Package.
(xiv) Neither the Company nor any of its subsidiaries is (A) in violation of its
charter or by-laws or (B) in default in the performance or observance of any material
obligation, agreement, covenant or condition contained in any contract,
9
indenture, mortgage, loan agreement, note, lease or other instrument to which
the Company or any of its subsidiaries is a party or by which it or any of them may
be bound, or to which any of the property or assets of the Company or any of its
subsidiaries is subject, except, in the case of clause (B), for any such default that
would not have a material adverse effect on the condition, financial or otherwise, or
on the earnings, business affairs or business prospects of the Company and its
subsidiaries considered as one enterprise; and the execution, delivery and
performance of this Agreement, the applicable Terms Agreement, the Underwritten
Securities being sold pursuant to the applicable Terms Agreement or the Indenture and
the consummation of the transactions contemplated herein and therein and compliance
by the Company with its obligations hereunder and thereunder, have been duly
authorized by all necessary corporate action and do not and will not conflict with or
constitute a breach of, or default under, or result in the creation or imposition of
any lien, charge or encumbrance upon any property or assets of the Company or any of
its subsidiaries pursuant to any contract, indenture, mortgage, loan agreement, note,
lease or other instrument to which the Company or any of its subsidiaries is a party
or by which it or any of them may be bound, or to which any of the property or assets
of the Company or any of its subsidiaries is subject, nor will such action result in
any violation of the provisions of the charter or by-laws of the Company or any
applicable law, administrative regulation or administrative or court order or decree.
(xv) The Company has operated and intends to continue to operate in such a
manner as to qualify to be taxed as a “real estate investment trust” under the
Internal Revenue Code of 1986, as amended (the “Code”), for the taxable year in which
sales of the Underwritten Securities are to occur.
(xvi) Neither the Company nor any of its subsidiaries is, and immediately after
giving effect to the sale of the Underwritten Securities in accordance with this
Agreement and the applicable Terms Agreement and the application of the proceeds as
described in the Prospectus under the caption “Use of Proceeds,” neither the Company
nor any of its subsidiaries will be, an “investment company” within the meaning of
the Investment Company Act of 1940, as amended (the “1940 Act”).
(xvii) There is no action, suit or proceeding before or by any court or
governmental agency or body, domestic or foreign, now pending, or, to the knowledge
of the Company, threatened, against or affecting the Company or any of its
subsidiaries, which is required to be disclosed in the Registration Statement, the
Prospectus or the General Disclosure Package (other than as disclosed therein), or
which might result in any material adverse change in the condition, financial or
otherwise, or in the earnings, business affairs or business prospects of the Company
and its subsidiaries considered as one enterprise, or which might materially and
adversely affect the properties or assets thereof or which might materially and
adversely affect the consummation of this Agreement, the applicable Terms Agreement
or the Indenture or the transactions contemplated herein or therein; all pending
legal or governmental proceedings to which the
10
Company or any of its subsidiaries is a party or of which any of its property or
assets is the subject which are not described in the Registration Statement, the
Prospectus and the General Disclosure Package, including ordinary routine litigation
incidental to the business, are, considered in the aggregate, not material; and there
are no contracts or documents of the Company or any of its subsidiaries which are
required to be filed as exhibits to the Registration Statement by the 1933 Act or by
the 1933 Act Regulations which have not been so filed.
(xviii) Neither the Company nor any of its subsidiaries is required to own or
possess any trademarks, service marks, trade names or copyrights in order to conduct
the business now operated by it, other than those the failure to possess or own would
not have a material adverse effect on the condition, financial or otherwise, or on
the earnings, business affairs or business prospects of the Company and its
subsidiaries considered as one enterprise.
(xix) No authorization, approval or consent of any court or governmental
authority or agency is required that has not been obtained in connection with the
consummation by the Company of the transactions contemplated by this Agreement, the
applicable Terms Agreement or the Indenture, except such as may be required under the
1933 Act, the 1939 Act or the 1933 Act Regulations or state securities laws or real
estate syndication laws.
(xx) The Company and its subsidiaries possess such certificates, authorities or
permits issued by the appropriate state, federal or foreign regulatory agencies or
bodies necessary to conduct the business now operated by them, other than those the
failure to possess or own would not have a material adverse effect on the condition,
financial or otherwise, or on the earnings, business affairs or business prospects of
the Company and its subsidiaries considered as one enterprise, and neither the
Company nor any of its subsidiaries has received any notice of proceedings relating
to the revocation or modification of any such certificate, authority or permit which,
singly or in the aggregate, if the subject of an unfavorable decision, ruling or
finding, would materially and adversely affect the condition, financial or otherwise,
or the earnings, business affairs or business prospects of the Company and its
subsidiaries considered as one enterprise.
(xxi) The Company has full corporate power and authority to enter into this
Agreement, the applicable Terms Agreement and the Delayed Delivery Contracts, if any,
and this Agreement has been, and as of each Representation Date, the applicable Terms
Agreement and the Delayed Delivery Contracts, if any, will have been, duly
authorized, executed and delivered by the Company.
(xxii) Except as otherwise disclosed in the Registration Statement, the
Prospectus and the General Disclosure Package and except as would not have a material
adverse effect on the condition, financial or otherwise, or on the earnings, business
affairs or business prospects of the Company and its subsidiaries considered as one
enterprise: (i) all properties and assets described in the Registration Statement,
the Prospectus or the General Disclosure Package are
11
owned with good and marketable title by the Company, its subsidiaries and/or a
joint venture or partnership in which any such party is a participant (a “Related
Entity”); (ii) all of the leases under which any of the Company, its subsidiaries or,
to the knowledge of the Company, Related Entities holds or uses real properties or
assets as a lessee are in full force and effect, and neither the Company, nor any of
its subsidiaries or, to the knowledge of the Company, Related Entities is in material
default in respect of any of the terms or provisions of any of such leases and no
claim has been asserted by anyone adverse to any such party’s rights as lessee under
any of such leases, or affecting or questioning any such party’s right to the
continued possession or use of the leased property or assets under any such leases;
(iii) all liens, charges, encumbrances, claims or restrictions on or affecting the
properties and assets of any of the Company, its subsidiaries or Related Entities
which are required to be disclosed in the Registration Statement, the Prospectus or
the General Disclosure Package are disclosed therein; (iv) neither the Company, nor
any of its subsidiaries or, to the knowledge of the Company, Related Entities nor any
lessee of any portion of any such party’s properties is in default under any of the
leases pursuant to which any of the Company, its subsidiaries or, to the knowledge of
the Company, Related Entities leases its properties and neither the Company, nor any
of its subsidiaries or Related Entities knows of any event which, but for the passage
of time or the giving of notice, or both, would constitute a default under any of
such leases; (v) no tenant under any of the leases pursuant to which any of the
Company, or its subsidiaries or, to the knowledge of the Company, Related Entities
leases its properties has an option or right of first refusal to purchase the
premises demised under such lease; (vi) each of the properties of any of the Company
or, to the knowledge of the Company, its subsidiaries or Related Entities complies
with all applicable codes and zoning laws and regulations; and (vii) neither the
Company nor any of its subsidiaries has knowledge of any pending or threatened
condemnation, zoning change or other proceeding or action that will in any manner
affect the size of, use of, improvements on, construction on, or access to the
properties of any of the Company, its subsidiaries or Related Entities.
(xxiii) Title insurance in favor of the mortgagee or the Company, its
subsidiaries and/or their Related Entities is maintained with respect to each
shopping center property owned by any such entity in an amount at least equal to (a)
the cost of acquisition of such property or (b) the cost of construction of such
property (measured at the time of such construction), except, in each case, where the
failure to maintain such title insurance would not have a material adverse effect on
the condition, financial or otherwise, or on the earnings, business affairs or
business prospects of the Company and its subsidiaries considered as one enterprise.
(xxiv) The mortgages and deeds of trust encumbering the properties and assets
described in the Registration Statement, the Prospectus or the General Disclosure
Package are not convertible nor does any of the Company or its subsidiaries hold a
participating interest therein.
12
(xxv) Each of the partnership and joint venture agreements to which the
Company or any of its subsidiaries is a party, and which relates to real property
described in the Registration Statement, the Prospectus or the General Disclosure
Package, has been duly authorized, executed and delivered by such applicable party
and constitutes the valid agreement thereof, enforceable in accordance with its
terms, except as limited by (a) the effect of bankruptcy, insolvency, reorganization,
moratorium or other similar laws now or hereafter in effect relating to or affecting
the rights or remedies of creditors or (b) the effect of general principles of
equity, whether enforcement is considered in a proceeding in equity or at law, and
the discretion of the court before which any proceeding therefor may be brought, and
the execution, delivery and performance of any of such agreements did not, at the
time of execution and delivery, and does not constitute a breach of, or default
under, the charter or by-laws of such party or any material contract, lease or other
instrument to which such party is a party or by which its properties may be bound or
any law, administrative regulation or administrative or court order or decree.
(xxvi) None of the Company or any of its subsidiaries has any knowledge of (a)
the unlawful presence of any hazardous substances, hazardous materials, toxic
substances or waste materials (collectively, “Hazardous Materials”) on any of the
properties owned by it or the Related Entities, or (b) any unlawful spills, releases,
discharges or disposal of Hazardous Materials that have occurred or are presently
occurring off such properties as a result of any construction on or operation and use
of such properties which presence or occurrence would have a material adverse effect
on the condition, financial or otherwise, or on the earnings, business affairs or
business prospects of the Company and its subsidiaries considered as one enterprise;
and in connection with the construction on or operation and use of the properties
owned by the Company, its subsidiaries and Related Entities, each of the Company and
its subsidiaries represents that it has no knowledge of any material failure to
comply with all applicable local, state and federal environmental laws, regulations,
ordinances and administrative and judicial orders relating to the generation,
recycling, reuse, sale, storage, handling, transport and disposal of any Hazardous
Materials.
(xxvii) The Company and each of its subsidiaries maintain a system of internal
accounting controls sufficient to provide reasonable assurances that (1)
transactions are executed in accordance with management’s general or specific
authorization; (2) transactions are recorded as necessary to permit preparation of
financial statements in conformity with United States generally accepted accounting
principles and to maintain accountability for assets; (3) access to assets is
permitted only in accordance with management’s general or specific authorization;
and (4) the recorded accountability for assets is compared with the existing assets
at reasonable intervals and appropriate action is taken with respect to any
differences. Except as described in the Registration Statement, the Prospectus and
the General Disclosure Package, since the end of the Company’s most recent audited
fiscal year, there has been (I) no material weakness in the Company’s internal
control over financial reporting (whether or not remediated)
13
and (II) no change in the Company’s internal control over financial reporting
that has materially affected, or is reasonably likely to materially affect, the
Company’s internal control over financial reporting.
The Company and its consolidated subsidiaries employ disclosure controls and
procedures that are designed to ensure that information required to be disclosed by
the Company in the reports that it files or submits under the 1934 Act is recorded,
processed, summarized and reported, within the time periods specified in the
Commission’s rules and forms, and is accumulated and communicated to the Company’s
management, including its principal executive officer or officers and principal
financial officer or officers, as appropriate, to allow timely decisions regarding
disclosure.
(xxviii) There is and has been no failure on the part of the Company or any of
the Company’s directors or officers, in their capacities as such, to comply in all
material respects with any provision of the Xxxxxxxx-Xxxxx Act of 2002 and the rules
and regulations promulgated in connection therewith (the “Xxxxxxxx-Xxxxx Act”),
including Section 402 related to loans and Sections 302 and 906 related to
certifications.
(xxix) The Registration Statement is not the subject of a pending proceeding or
examination under Section 8(d) or 8(e) of the 1933 Act, and the Company is not the
subject of a pending proceeding under Section 8A of the 1933 Act in connection with
the offering of the Securities.
(b) Any certificate signed by any officer of the Company and delivered to you or to counsel
for the Underwriters in connection with the offering of the Underwritten Securities shall be deemed
a representation and warranty by the Company to each Underwriter participating in such offering as
to the matters covered thereby on the date of such certificate and, unless subsequently amended or
supplemented, at each Representation Date subsequent thereto.
(c) Each Underwriter, separately and not jointly, represents and agrees that:
(i) In relation to each Member State of the European Economic area which has
implemented the Prospectus Directive (each, a “Relevant Member State”), with effect
from and including the date on which the Prospectus Directive is implemented in that
Relevant Member State (the “Relevant Implementation Date”) it has not made and will
not make an offer of Underwritten Securities being sold pursuant to the applicable
Terms Agreement which are the subject of the offering contemplated by the related
prospectus supplement to the public in that Relevant Member State other than:
(1) to legal entities which are authorized or regulated to operate in the
financial markets or, if not so authorized or regulated, whose corporate
purpose is solely to invest in securities;
(2) to any legal entity which has two or more of (1) an average of at least
250 employees during the last financial year; (2) a total balance
14
sheet of more than €43,000,000; and (3) an annual net turnover of more than
€50,000,000 as shown in its last annual or consolidated accounts;
(3) to fewer than 100 natural or legal persons (other than qualified
investors as defined in the Prospectus Directive) subject to obtaining the
prior consent of the lead manager; or
(4) in any other circumstances falling within Article 3(2) of the Prospectus
Directive,
provided that no such offer of such Underwritten Securities shall require the
Company or any Underwriter to publish a prospectus pursuant to Article 3 of the
Prospectus Directive.
For the purposes of this provision, the expression an “offer of Underwritten
Securities to the public” in relation to any such Underwritten Securities in any
Relevant Member State means the communication in any form and by any means of
sufficient information on the terms of the offer and the Underwritten Securities to
be offered so as to enable an investor to decide to purchase or subscribe such
Underwritten Securities, as the same may be varied in that Member State by any
measure implementing the Prospectus Directive in that Member State and the
expression “Prospectus Directive” means Directive 2003/71/ EC and includes any
relevant implementing measure in each Relevant Member State.
(ii) it has only communicated or caused to be communicated and will only
communicate or cause to be communicated any invitation or inducement to engage in
investment activity (within the meaning of Section 21 of the Financial Services and
Markets Acts 2000 (“FSMA”) received by it in connection with the issue or sale of
such Underwritten Securities in circumstances in which Section 21(1) of the FSMA does
not apply to the Company; and
(iii) it has complied and will comply with all applicable provisions of the FSMA
with respect to anything done by it in relation to such Underwritten Securities in,
from or otherwise involving the United Kingdom.
Section 2. Purchase and Sale.
(a) The several commitments of the Underwriters to purchase the Underwritten Securities
pursuant to the applicable Terms Agreement shall be deemed to have been made on the basis of the
representations and warranties herein contained and shall be subject to the terms and conditions
herein set forth.
(b) In addition, on the basis of the representations and warranties herein contained and
subject to the terms and conditions herein set forth, the Company may grant, if so provided in the
applicable Terms Agreement relating to the Initial Underwritten Securities, an option to the
Underwriters named in such Terms Agreement, severally and not jointly, to purchase up to the
aggregate principal amount of Option Securities set forth therein at the same price per Option
15
Security as is applicable to the Initial Underwritten Securities. Such option, if granted,
will expire 30 days (or such lesser number of days as may be specified in the applicable Terms
Agreement) after the date of such Terms Agreement relating to the Initial Underwritten Securities,
and may be exercised in whole or in part from time to time only for the purpose of covering
over-allotments which may be made in connection with the offering and distribution of the Initial
Underwritten Securities upon notice by you to the Company setting forth the aggregate principal
amount of Option Securities as to which the several Underwriters are then exercising the option and
the time, date and place of payment and delivery for such Option Securities. Any such time and date
of delivery (a “Date of Delivery”) shall be determined by you, but shall not be later than seven
full business days and not be earlier than two full business days after the exercise of said
option, nor in any event prior to Closing Time, unless otherwise agreed upon by you and the
Company. If the option is exercised as to all or any portion of the Option Securities, each of the
Underwriters, acting severally and not jointly, will purchase that proportion of the total
aggregate principal amount of Option Securities then being purchased which the aggregate principal
amount of Initial Underwritten securities each such Underwriter has severally agreed to purchase as
set forth in the applicable Terms Agreement bears to the total aggregate principal amount of
Initial Underwritten securities (except as otherwise provided in the applicable Terms Agreement).
(c) Payment of the purchase price for, and delivery of, the Underwritten Securities to be
purchased by the Underwriters shall be made at the office of Sidley Austin llp, 000
Xxxxxxx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000, or at such other place as shall be agreed upon by you and
the Company, at 9:00 A.M., New York City time, on the third (or fourth, if the applicable Terms
Agreement is entered into after 4:30 P.M. (Eastern Time) on any given day) business day (unless
postponed in accordance with the provisions of Section 10 hereof) following the date of the
applicable Terms Agreement or at such other time as shall be agreed upon by you and the Company
(each such time and date being referred to as a “Closing Time”). In addition, in the event that any
or all of the Option Securities are purchased by the Underwriters, payment of the purchase price
for, and delivery of certificates representing, such Option Securities, shall be made at the
above-mentioned office of Sidley Austin llp, or at such other place as shall be agreed
upon by you and the Company on each Date of Delivery as specified in the notice from you to the
Company. Unless otherwise specified in the applicable Terms Agreement, payment shall be made to
the Company by wire transfer or certified or official bank check or checks in Federal or similar
same-day funds payable to the order of the Company against delivery to you for the respective
accounts of the Underwriters for the Underwritten Securities to be purchased by them. The
Underwritten Securities shall be in such authorized denominations and registered in such names as
you may request in writing at least one business day prior to the applicable Closing Time or Date
of Delivery, as the case may be. The Underwritten Securities, which may be in temporary form, will
be made available for examination and packaging by you on or before the first business day prior to
the Closing Time or the Date of Delivery, as the case may be.
If authorized by the applicable Terms Agreement, the Underwriters named therein may solicit
offers to purchase Underwritten Securities from the Company pursuant to delayed delivery contracts
(“Delayed Delivery Contracts”) substantially in the form of Exhibit B hereto with such changes
therein as the Company may approve. As compensation for arranging Delayed Delivery Contracts, the
Company will pay to you at Closing Time, for the respective accounts of the Underwriters, a fee
equal to that percentage of the principal amount of
16
Underwritten Securities for which Delayed Delivery Contracts are made at the Closing Time as
is specified in the applicable Terms Agreement. Any Delayed Delivery Contracts are to be with
institutional investors of the types described in the Prospectus. At the Closing Time, the Company
will enter into Delayed Delivery Contracts (for not less than the minimum principal amount of
Underwritten Securities per Delayed Delivery Contract specified in the applicable Terms Agreement)
with all purchasers proposed by the Underwriters and previously approved by the Company as provided
below, but not for an aggregate principal amount of Underwritten Securities in excess of that
specified in the applicable Terms Agreement. The Underwriters will not have any responsibility for
the validity or performance of Delayed Delivery Contracts.
You shall submit to the Company, at least two business days prior to the Closing Time, the
names of any institutional investors with which it is proposed that the Company will enter into
Delayed Delivery Contracts and the principal amount of Underwritten Securities to be purchased by
each of them, and the Company will advise you, at least two business days prior to the Closing
Time, of the names of the institutions with which the making of Delayed Delivery Contracts is
approved by the Company and the principal amount of Underwritten Securities to be covered by each
such Delayed Delivery Contract.
The principal amount of Underwritten Securities agreed to be purchased by the several
Underwriters pursuant to the applicable Terms Agreement shall be reduced by the principal amount of
Underwritten Securities covered by Delayed Delivery Contracts, as to each Underwriter as set forth
in a written notice delivered by you to the Company; provided, however, that the total principal
amount of Underwritten Securities to be purchased by all Underwriters shall be the total amount of
Underwritten Securities covered by the applicable Terms Agreement, less the principal amount of
Underwritten Securities covered by Delayed Delivery Contracts.
Section 3. Covenants of the Company. The Company covenants with you and with each
Underwriter participating in the offering of Underwritten Securities, as follows:
(a) The Company, subject to Section 3(b), will comply with the requirements of Rule 430B and
will notify you as soon as reasonably possible, (i) when any post-effective amendment to the
Registration Statement or a new registration statement relating to the Securities shall become
effective, or any amendment or supplement to the Prospectus or any preliminary prospectus shall
have been filed, (ii) of the receipt of any comments from the Commission, (iii) of any request by
the Commission for any amendment to the Registration Statement or the filing of a new registration
statement or any amendment or supplement to the Prospectus or any preliminary prospectus or any
document incorporated by reference therein or otherwise deemed to be a part thereof or for
additional information, (iv) of the issuance by the Commission of any stop order suspending the
effectiveness of the Registration Statement or such new registration statement or of any order
preventing or suspending the use of the Prospectus or any preliminary prospectus, or of the
suspension of the qualification of the Underwritten Securities for offering or sale in any
jurisdiction, or of the initiation or threatening of any proceedings for any of such purposes or of
any examination pursuant to Section 8(e) of the 1933 Act concerning the Registration Statement and
(v) if the Company becomes the subject of a proceeding under Section 8A of the 1933 Act in
connection with the offering of the Underwritten Securities or if the Company receives from the
Commission a notice pursuant to Rule 401(g)(2) of the 1933 Act Regulations. The Company will
effect the filings required under Rule 424(b), in the manner and
17
within the time period required by Rule 424(b) (without reliance on Rule 424(b)(8)), and will
take such steps as it deems necessary to ascertain promptly whether the form of prospectus
transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the
event that it was not, it will promptly file such prospectus. The Company will make reasonable
efforts to prevent the issuance of any stop order and, if any stop order is issued, to obtain the
lifting thereof as soon as reasonably possible. The Company shall pay the required Commission
filing fees relating to the Underwritten Securities within the time required by Rule 456(b)(1)(i)
of the 1933 Act Regulations without regard to the proviso therein and otherwise in accordance with
Rules 456(b) and 457(r) of the 1933 Act Regulations (including, if applicable, by updating the
“Calculation of Registration Fee” table in accordance with Rule 456(b)(1)(ii) either in a
post-effective amendment to the Registration Statement or on the cover page of a prospectus filed
pursuant to Rule 424(b)).
(b) The Company will notify you immediately, and if written notice is requested by you,
confirm such notice in writing as soon as reasonably practicable, of any change in or withdrawal of
the rating assigned by a nationally recognized statistical rating organization to any long-term
debt securities of the Company or the public announcement by any nationally recognized statistical
rating organization that it has under surveillance or review its rating of any long-term debt
securities of the Company. The Company will give you notice of its intention to file or prepare
any amendment to the Registration Statement or a new registration statement relating to the
Securities or any amendment or supplement to any preliminary prospectus (including the base
prospectus included in the Original Registration Statement or amendment thereto at the time it
became effective) or to the Prospectus, whether pursuant to the 1933 Act, the 1934 Act or
otherwise, and the Company will furnish you with copies of any such documents a reasonable amount
of time prior to such proposed filing or use, as the case may be, and will not file or use any such
document to which you or counsel for the Underwriters shall reasonably object. The Company will
prepare a final term sheet (the “Final Term Sheet”) reflecting the final terms of the Underwritten
Securities, in form and substance satisfactory to the Underwriters and attached as an exhibit to
the applicable Terms Agreement, and shall promptly file such Final Term Sheet as an “issuer free
writing prospectus” pursuant to Rule 433 as soon as possible after the execution of such Terms
Agreement.
(c) The Company has furnished or will deliver to you and counsel for the Underwriters, upon
written request, signed copies of the Original Registration Statement as originally filed and any
new registration statement containing the Prospectus and, in each case, any amendment thereto
(including exhibits filed therewith or incorporated by reference therein and documents incorporated
or deemed to be incorporated by reference therein or otherwise deemed to be a part thereof) and
signed copies of all consents and certificates of experts, and will also deliver to you, upon
written request, a conformed copy of the Original Registration Statement as originally filed and
any new registration statement containing the Prospectus and, in each case, any amendment thereto
(without exhibits) for each of the Underwriters. The copies of the Original Registration Statement
and any new registration statement and, in each case, any amendment thereto furnished to the
Underwriters will be identical to the electronically transmitted copies thereof filed with the
Commission pursuant to XXXXX, except to the extent permitted by Regulation S-T.
18
(d) The Company will deliver to each Underwriter as many copies of each preliminary prospectus
and any amendment or supplement thereto as such Underwriter reasonably requests, and the Company
hereby consents to the use of such copies for purposes permitted by the 1933 Act. The Company will
furnish to each Underwriter, during the period when the Prospectus is required to be delivered (or
but for the exception afforded by Rule 172 of the 1933 Act Regulations would be required to be
delivered) under the 1933 Act or the 1934 Act in connection with sales of the Underwritten
Securities, such number of copies of the Prospectus (as amended or supplemented) as such
Underwriter may reasonably request. Each preliminary prospectus and the Prospectus and any
amendment or supplement thereto furnished to the Underwriters will be identical to the
electronically transmitted copies thereof filed with the Commission pursuant to XXXXX, except to
the extent permitted by Regulation S-T.
(e) The Company will comply with the 1933 Act and the 1933 Act Regulations, the 1934 Act and
the 1934 Act Regulations and the 1939 Act and the 1939 Act Regulations so as to permit the
completion of the distribution of the Underwritten Securities as contemplated in this Agreement,
the applicable Terms Agreement and in the Prospectus. If at any time when the Prospectus is
required to be delivered (or but for the exception afforded by Rule 172 of the 1933 Act Regulations
would be required to be delivered) under the 1933 Act or the 1934 Act in connection with sales of
the Underwritten Securities, any event shall occur or condition shall exist as a result of which it
is necessary, in the opinion of counsel for the Underwriters or counsel for the Company, to amend
the Registration Statement in order that the Registration Statement will not contain an untrue
statement of a material fact or omit to state a material fact required to be stated therein or
necessary to make the statements therein not misleading or amend or supplement the Prospectus or
the General Disclosure Package in order that the Prospectus or the General Disclosure Package, as
the case may be, will not include an untrue statement of a material fact or omit to state any
material fact necessary in order to make the statements therein not misleading in the light of the
circumstances existing at the time it is delivered to a purchaser, or if it shall be necessary, in
the opinion of either such counsel, at any such time to amend the Registration Statement, to file a
new registration statement or to amend or supplement the Prospectus or the General Disclosure
Package in order to comply with the requirements of the 1933 Act or the 1933 Act Regulations
(including, with respect to the filing of a new registration statement, if at any time the Company
is no longer eligible to use an automatic shelf registration statement), the Company will promptly
prepare and file with the Commission, subject to Section 3(b) and Section 3(m), such amendment,
supplement or new registration statement as may be necessary to correct such statement or omission
or to comply with such requirements, the Company will use its best efforts to have such amendment
or new registration statement declared effective as soon as practicable (if it is not an automatic
shelf registration statement with respect to the Underwritten Securities) and the Company will
furnish to the Underwriters such number of copies of such amendment, supplement or new registration
statement as the Underwriters may reasonably request. If, prior to the completion of the public
offer and sale of the Underwritten Securities (which completion you shall promptly communicate to
the Company), at any time following issuance of an Issuer Free Writing Prospectus there occurred or
occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted
or would conflict with the information then contained in the Registration Statement (or any other
registration statement relating to the Underwritten Securities) or the Prospectus or included or
would include an untrue statement of a material fact or omitted or would omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances
19
prevailing at that subsequent time, not misleading, the Company will promptly (i) notify you
and (ii) either (1) amend or supplement such Issuer Free Writing Prospectus to eliminate or correct
such conflict, untrue statement or omission or (2) file a report with the Commission under the 1934
Act that corrects such untrue statement or omission and notify you in writing that such Issuer Free
Writing Prospectus shall no longer be used.
(f) The Company will endeavor, in cooperation with the Underwriters, to qualify the
Underwritten Securities and the shares of Common Stock or Preferred Stock issuable upon conversion
of the Underwritten Securities, if applicable, for offering and sale under the applicable
securities laws and real estate syndication laws of such states and other jurisdictions of the
United States as you may designate. In each jurisdiction in which the Underwritten Securities and
the shares of Common Stock or Preferred Stock issuable upon conversion of the Underwritten
Securities, if applicable, have been so qualified, the Company will file such statements and
reports as may be required by the laws of such jurisdiction to continue such qualification in
effect for so long as may be required for the distribution of the Underwritten Securities and the
shares of Common Stock or Preferred Stock issuable upon conversion of the Underwritten Securities,
if applicable; provided, however, that the Company shall not be obligated to qualify as a foreign
corporation in any jurisdiction where it is not so qualified.
(g) The Company will timely file such reports pursuant to the 1934 Act as are necessary in
order to make generally available to its securityholders as soon as practicable an earnings
statement (in form complying with the provisions of Rule 158 of the 1933 Act Regulations) for the
purposes of, and to provide to the Underwriters the benefits contemplated by, the last paragraph of
Section 11(a) of the 1933 Act.
(h) The Company will use its best efforts to meet the requirements to qualify as a “real
estate investment trust” under the Code for the taxable year in which sales of the Underwritten
Securities are to occur.
(i) The Company, during the period when the Prospectus is required to be delivered (or but for
the exception afforded by Rule 172 of the 1933 Act Regulations would be required to be delivered)
under the 1933 Act or the 1934 Act in connection with sales of the Underwritten Securities, will
file all documents required to be filed with the Commission pursuant to Section 13, 14 or 15 of the
1934 Act within the time period prescribed by the 1934 Act and the 1934 Act Regulations.
(j) The Company will not, between the date of the applicable Terms Agreement and the Closing
Time with respect to the Underwritten Securities covered thereby, without your prior written
consent, which shall not be unreasonably withheld, offer or sell, grant any option for the sale of,
or enter into any agreement to sell, any debt securities of the Company with a maturity of more
than one year (other than the Underwritten Securities which are to be sold pursuant to such Terms
Agreement) or, if such Terms Agreement relates to Underwritten Securities that are convertible into
Common Stock or Preferred Stock, any Common Stock or Preferred Stock or any security convertible
into Common Stock or Preferred Stock (except for Common Stock or Preferred Stock issued pursuant to
reservations, agreements, employee benefit plans, dividend reinvestment plans, or employee and
director stock option plans), except as may otherwise be
20
provided in the applicable Terms Agreement. You may release us from the obligations of this
Section 3(j) in your sole discretion at any time without notice.
(k) If the Underwritten Securities are convertible into Common Stock or Preferred Stock, the
Company will reserve and keep available at all times, free of preemptive or other similar rights, a
sufficient number of shares of Common Stock or Preferred Stock, as the case may be, for the purpose
of enabling the Company to satisfy any obligation to issue such shares upon conversion of the
Underwritten Securities.
(l) If the Underwritten Securities are convertible into Common Stock or Preferred Stock, the
Company will use its best efforts to list shares of Common Stock or Preferred Stock, as the case
may be, issuable upon conversion of the Underwritten Securities on the New York Stock Exchange,
Inc. or such other national exchange on which the Company’s Common Stock or Preferred Stock, as the
case may be, is then listed.
(m) The Company represents and agrees that, unless it obtains your prior consent, and each
Underwriter represents and agrees that, unless it obtains your prior consent and the prior consent
of the Company, it has not made and will not make any offer relating to the Underwritten Securities
that would constitute an “issuer free writing prospectus,” as defined in Rule 433, or that would
otherwise constitute a “free writing prospectus,” as defined in Rule 405, required to be filed with
the Commission; provided, however, that the Underwriters are authorized to use any free writing
prospectus that contains substantially only information specified in the Final Term Sheet. Any
such free writing prospectus consented to by the Company and you is hereinafter referred to as a
“Permitted Free Writing Prospectus.” The Company represents that it has treated or agrees that it
will treat each Permitted Free Writing Prospectus as an “issuer free writing prospectus,” as
defined in Rule 433, and has complied and will comply with the requirements of Rule 433 applicable
to each and every Permitted Free Writing Prospectus, including timely filing with the Commission
where required, legending and record keeping.
(n) The date of any agreement by an Underwriter to act as principal or agent in connection
with the Underwritten Securities is not more than three years subsequent to the later of the
initial effective date of the Registration Statement or December 1, 2005. If, immediately prior to
the third anniversary of the later of the initial effective date of the Registration Statement or
December 1, 2005, any of such Underwritten Securities remain unsold by the applicable
Underwriter(s) and a prospectus is required to be delivered by such Underwriter(s) under the 1933
Act or the 1934 Act in connection with the sale of such Underwritten Securities, the Company will
prior to that third anniversary file, if it has not already done so, a new shelf registration
statement relating to such Underwritten Securities, will use its reasonable best efforts to cause
such registration statement to be declared effective within 180 days after that third anniversary,
and will take all other reasonable actions necessary or appropriate to permit the public offering
and sale of such Underwritten Securities to continue as contemplated in the expired registration
statement relating to such Underwritten Securities. References herein to the “Registration
Statement” shall include such new shelf registration statement.
(o) The Company will apply the net proceeds from the sale of the Underwritten Securities as
set forth under “Use of Proceeds” in the Prospectus.
21
Section 4. Payment of Expenses. The Company will pay all expenses incident to the
performance of its obligations under this Agreement or the applicable Terms Agreement, including
(i) the preparation, printing and filing of the Registration Statement as originally filed and any
new registration statement containing the Prospectus and, in each case, any amendment thereto, (ii)
the printing and filing of this Agreement and the applicable Terms Agreement, (iii) the
preparation, issuance and delivery of the Underwritten Securities to the Underwriters, (iv) the
fees and disbursements of the Company’s counsel and accountants, of the Trustee and its counsel and
of any applicable calculation agent or exchange rate agent, (v) the qualification of the
Underwritten Securities and the shares of Common Stock or Preferred Stock issuable upon conversion
of the Underwritten Securities, if applicable, under securities laws and real estate syndication
laws in accordance with the provisions of Section 3(f), including filing fees and the fees and
disbursements of counsel for the Underwriters in connection therewith and in connection with the
preparation of the Blue Sky Survey and any supplement thereto, (vi) the printing and delivery to
the Underwriters of copies of the Registration Statement as originally filed and any new
registration statement containing the Prospectus, each preliminary prospectus, any Issuer Free
Writing Prospectus and the Prospectus and any amendments or supplements thereto and any costs
associated with electronic delivery of any of the foregoing by the Underwriters to investors, (vii)
any fees charged by nationally recognized statistical rating organizations for the rating of the
Underwritten Securities, (viii) the fees and expenses, if any, incurred with respect to the listing
of the Underwritten Securities and the shares of Common Stock or Preferred Stock issuable upon
conversion of the Underwritten securities, if applicable, on any national securities exchange, (ix)
the fees and expenses, if any, incurred with respect to any filing with the National Association of
Securities Dealers, Inc., (x) the cost of providing any CUSIP or other identification numbers for
the Underwritten Securities or the shares of Common Stock or Preferred Stock issuable upon
conversion of the Underwritten Securities, if applicable, and (xi) the fees and expenses of any
depositary in connection with the Underwritten Securities.
If the applicable Terms Agreement is terminated by you in accordance with the provisions of
Section 5, or Section 9(b)(i) or 9(b)(iii) (only with respect to the Company’s securities), the
Company shall reimburse the Underwriters named in such Terms Agreement for all of their
out-of-pocket expenses, including the reasonable fees and disbursements of counsel for the
Underwriters.
Section 5. Conditions of Underwriters’ Obligations. The several obligations of the
Underwriters to purchase Underwritten Securities pursuant to the applicable Terms Agreement are
subject to the accuracy of the representations and warranties of the Company herein contained, to
the accuracy of the statements of the Company’s officers made in any certificate pursuant to the
provisions hereof, to the performance by the Company of all of its covenants and other obligations
hereunder, and to the following further conditions:
(a) At Closing Time, (i) the Registration Statement has become effective and no stop order
suspending the effectiveness of the Registration Statement shall have been issued under the 1933
Act or proceedings therefor initiated or threatened by the Commission, and any request on the part
of the Commission for additional information shall have been complied with to the reasonable
satisfaction of counsel to the Underwriters, (ii) each preliminary prospectus and the Prospectus
containing the Rule 430B Information shall have been filed with the Commission in the manner and
within the time period required by Rule 424(b) without reliance on Rule
22
424(b)(8) (or a post-effective amendment providing such information shall have been filed and
become effective in accordance with the requirements of Rule 430B), (iii) the Final Term Sheet and
any other material required to be filed by the Company pursuant to Rule 433(d) of the 1933 Act
Regulations shall have been filed with the Commission within the applicable time periods prescribed
for such filings under such Rule 433, (iv) the Company shall have paid the required Commission
filing fees relating to the Underwritten Securities within the time period required by Rule
456(b)(1)(i) of the 1933 Act Regulations without regard to the proviso therein and otherwise in
accordance with Rules 456(b) and 457(r) of the 1933 Act Regulations and, if applicable, shall have
updated the “Calculation of Registration Fee” table in accordance with Rule 456(b)(1)(ii) either in
a post-effective amendment to the Registration Statement or on the cover page of a prospectus filed
pursuant to Rule 424(b), (v) the rating assigned by any nationally recognized statistical rating
organization to any long-term debt securities of the Company as of the date of the applicable Terms
Agreement shall not have been lowered or withdrawn since such date nor shall any such rating
organization have publicly announced that it has any long-term debt securities of the Company under
surveillance or review and (vi) there shall not have come to your attention any facts that would
cause you to believe that the Prospectus, at the time it was required to be delivered or made
available to purchasers of the Underwritten Securities, included an untrue statement of a material
fact or omitted to state a material fact necessary in order to make the statements therein, in
light of the circumstances existing at such time, not misleading.
(b) At Closing Time, you shall have received:
(1) The favorable opinion, dated as of the Closing Time, of Xxxxxx & Xxxxxxx LLP,
counsel for the Company, in form and substance satisfactory to counsel for the Underwriters,
to the effect that:
(i) The Underwritten Securities, when executed, issued and authenticated in
accordance with the terms of the Indenture and delivered to and paid in accordance
with the terms of the applicable Terms Agreement or the Delayed Delivery Contracts,
if any, will be valid and legally binding obligations of the Company enforceable in
accordance with their terms.
(ii) The Indenture is the valid and legally binding agreement of the Company,
enforceable against the Company in accordance with its terms.
(iii) The Indenture has been duly qualified under the 1939 Act.
(iv) The Registration Statement has become effective under the 1933 Act; and,
with consent from the Underwriters and their counsel, and, to the best of such
counsel’s knowledge, based solely on a telephonic confirmation by a member of the
Staff of the Commission, no stop order suspending the effectiveness of the
Registration Statement has been issued under the 1933 Act and no proceedings thereof
have been initiated or threatened by the Commission.
(v) The Registration Statement and the Prospectus (excluding the documents
incorporated by reference therein), as of their respective effective or
23
issue dates, appeared on their face to be appropriately responsive in all
material respects to the requirements for registration statements on Form S-3 under
the 1933 Act and the 1933 Act Regulations, other than Regulation S-T, the Trustee’s
Statement of Eligibility on Form T-1 (the “Form T-1”) or the financial statements,
schedules, or other financial and statistical data, included therein, incorporated by
reference therein, or omitted therefrom, as to which such counsel need express no
opinion, it being understood that in passing upon compliance as to form of the
Registration Statement and the Prospectus, such counsel may assume that the
statements made therein are correct and complete.
(vi) Each of the documents incorporated by reference in the Registration
Statement, the Prospectus or the preliminary prospectus supplement, when they were
filed with the Commission appeared on their face to be appropriately responsive in
all material respects to the applicable requirements for reports on Forms 10-K, 10-Q
and 8-K, and definitive proxy statements under Regulation 14A, as the case may be,
under the 1934 Act and the rules and regulations of the Commission thereunder, other
than the Form T-1, or the financial statements, schedules or other financial and
statistical data, included therein, incorporated by reference therein, or omitted
therefrom, as to which such counsel need express no opinion. In passing upon
compliance as to form of such documents, such counsel may assume that the statements
made therein are correct and complete.
(vii) The statements in the base prospectus under the caption “Description of
Debt Securities,” as supplemented and modified by the statements under the caption
“Description of the Notes” in the preliminary prospectus supplement and the final
prospectus supplement, insofar as they purport to describe or summarize certain
provisions of the Underwritten Securities or the Indenture, are accurate descriptions
or summaries in all material respects.
(viii) The execution and delivery of this Agreement and the applicable Terms
Agreement and the issuance and sale of the Underwritten Securities by the Company
pursuant to this Agreement and the applicable Terms Agreement or the Indenture, do
not require any consents, approvals or authorizations to be obtained by the Company
from, or any registrations, declarations or filings to be made by the Company with,
governmental authority under any federal or New York State statute, rule or
regulation applicable to the Company that have not been obtained or made except such
as may be required under the 1933 Act, the 1934 Act, the 1939 Act, or the rules and
regulations of the Commission thereunder and state securities laws or real estate
syndication laws, nor will such action result in a violation of any applicable
federal or New York State law or administrative regulation applicable to the Company.
(ix) The Company is not, and immediately after giving effect to the sale of the
Underwritten Securities in accordance with this Agreement and the applicable Terms
Agreement and the application of the proceeds as described in
24
the Prospectus under the caption “Use of Proceeds,” will not be, required to be
registered as an “investment company” within the meaning of the 1940 Act.
(x) Commencing with the Company’s taxable year beginning January 1, 1992, the
Company has been organized in conformity with the requirements for qualification as a
“real estate investment trust,” and its proposed method of operation will enable it
to meet the requirements for qualification and taxation as a “real estate investment
trust” under the Code, provided that such counsel’s opinion as to this matter shall
be conditioned upon certain representations as to factual matters made by the Company
to such counsel as described therein.
(xi) The statements set forth (a) in the Registration Statement under the
caption “Material United States Federal Income Tax Considerations to Us of Our REIT
Election” and (b) in the Prospectus and the General Disclosure Package under the
caption “Certain United States Material Federal Income Tax Consequences,” insofar as
they purport to summarize certain provisions of the statutes or regulations referred
to therein, are accurate summaries in all material respects.
The opinions rendered in (i) and (ii) of subsection (b)(1) are subject to the following
exceptions, limitations and qualifications: (i) the effect of bankruptcy, insolvency,
reorganization, fraudulent transfer, moratorium or other similar laws relating to or affecting the
rights and remedies of creditors; (ii) the effect of general principles of equity, whether
enforcement is considered in a proceeding in equity or at law (including the possible
unavailability of specific performance of injunctive relief), concepts of materiality,
reasonableness, good faith and fair dealing and the discretion of the court before which any
proceeding therefor may be brought; (iii) the unenforceability under certain circumstances under
law or court decisions of provisions providing for the indemnification of or contribution to a
party with respect to a liability where such indemnification or contribution is contrary to public
policy; and (iv) no opinion need be rendered concerning the enforceability of the waiver of rights
or defenses contained in Section 514 of the Indenture.
(2) The favorable opinion, dated as of the Closing Time, of Xxxxxxx LLP, Maryland
counsel to the Company, in form and substance satisfactory to counsel for the Underwriters,
to the effect that:
(i) The Company is a corporation duly incorporated and existing under the laws
of the State of Maryland and is in good standing with the State Department of
Assessments and Taxation of Maryland.
(ii) The Company has the corporate power to own, lease and operate its
properties and to conduct its business as described in the General Disclosure Package
and the Prospectus and to enter into and perform its obligations under this Agreement
and the applicable Terms Agreement and the Indenture.
(iii) The execution, delivery and performance of this Agreement, the applicable
Terms Agreement and the Delayed Delivery Contracts, if any, have
25
been duly authorized by the Company. This Agreement, the applicable Terms
Agreement and any Delayed Delivery Contracts, if any, have been duly executed and
delivered by the Company to the Underwriters.
(iv) The execution, delivery and performance of the Indenture has been duly
authorized by the Company and the Indenture has been executed and delivered by the
Company.
(v) The execution, delivery and performance of the Underwritten Securities have
been duly authorized by the Company.
(vi) The Underwritten Securities have been duly executed and delivered by the
Company.
(vii) The statements in the Prospectus under the captions “Description of Common
Stock” or “Description of Preferred Stock,” as applicable, as well as statements
under comparable captions in the applicable prospectus supplement, to the extent that
such statements describe shares of Common Stock or Preferred Stock, insofar as they
purport to constitute a summary of the terms of the shares of Common Stock or
Preferred Stock issuable upon conversion of the Underwritten Securities, if any, are
accurate summaries thereof in all material respects.
(viii) The shares of Common Stock or Preferred Stock issuable upon conversion of
the Underwritten Securities, if applicable, have been duly authorized for issuance
upon such conversion by the Company and such shares, when issued upon such
conversion, will be validly issued, fully paid and non-assessable, and the issuance
of such shares upon such conversion will not be subject to preemptive or other
similar rights arising under Maryland General Corporation Law, or the charter or the
by-laws of the Company. The Company has authorized the reservation of the shares of
Common Stock or Preferred Stock issuable upon conversion of the Underwritten
Securities.
(ix) No authorization, approval or consent of any Maryland governmental
authority or agency is required under any Maryland state statute, rule or regulation
applicable to the Company, that has not been obtained in connection with the
consummation by the Company of the transactions contemplated by this Agreement, the
applicable Terms Agreement or the Indenture (except that no opinion need by expressed
with respect to the applicability or effect of the securities laws of the State of
Maryland).
(3) The favorable opinion, dated as of the Closing Time, of Xxxxxx X. Xxxxxxxx, Esq.,
counsel for the Company, or other counsel satisfactory to the Underwriters, in form and
substance satisfactory to counsel for the Underwriters, to the effect that:
(i) The Company is duly qualified as a foreign corporation to transact business
and is in good standing in each jurisdiction in which it owns or leases real
property, except where the failure to so qualify would not have a material adverse
26
effect on the condition, financial or otherwise, or on the earnings, business
affairs or business prospects of the Company and its subsidiaries considered as one
enterprise.
(ii) To the best of his knowledge and information, the outstanding stock of the
Company was not issued in violation of the preemptive or other similar rights of any
securityholder of the Company.
(iii) To the best of his knowledge and information, the issuance of the shares
of Common Stock or Preferred Stock issuable upon conversion of the Underwritten
Securities, if applicable, will not be subject to the preemptive or other similar
rights of any securityholder of the Company.
(iv) To the best of his knowledge and information, there are no legal or
governmental proceedings pending or threatened which are required to be disclosed in
the Prospectus or the General Disclosure Package, other than those disclosed therein,
and all pending legal or governmental proceedings to which the Company or any of its
subsidiaries is a party or of which any of the property of the Company or its
subsidiaries is the subject which are not described in the Prospectus and the General
Disclosure Package, including ordinary routine litigation incidental to the business,
are, considered in the aggregate, not material.
(v) To the best of his knowledge and information, there are no contracts,
indentures, mortgages, loan agreements, notes, leases or other instruments required
to be described or referred to in the Registration Statement, the Prospectus and the
General Disclosure Package or to be filed as exhibits to the Registration Statement
other than those described or referred to therein or filed as exhibits thereto, the
descriptions thereof or references thereto are correct, and, to the best of his
knowledge and information, no default exists in the due performance or observance of
any material obligation, agreement, covenant or condition contained in any contract,
indenture, mortgage (except as otherwise described in the Prospectus or the General
Disclosure Package), loan agreement, note, lease or other instrument so described,
referred to or filed which would have a material adverse effect on the condition,
financial or otherwise, or on the earnings, business or business prospects of the
Company and its subsidiaries considered as one enterprise.
(vi) To the best of his knowledge and information, the execution and delivery of
this Agreement, the applicable Terms Agreement, the Underwritten Securities being
sold pursuant to the applicable Terms Agreement and the Indenture and the
consummation of the transactions contemplated herein and therein and compliance by
the Company with its obligations hereunder and thereunder will not conflict with or
constitute a breach of, or default under, or result in the creation or imposition of
any lien, charge or encumbrance upon any property or assets of the Company or any of
its subsidiaries pursuant to any contract, indenture, mortgage, loan agreement, note,
lease or other instrument to which the Company or any of its subsidiaries is a party
or by which it or any of
27
them may be bound or to which any of the property or assets of the Company or
any of its subsidiaries is subject, nor will such action result in violation of the
provisions of the charter or by-laws of the Company or any applicable law,
administrative regulation or administrative or court order or decree.
(vii) Each of the partnership and joint venture agreements to which the Company
or any of its subsidiaries is a party, and which relates to real property described
in the Prospectus and the General Disclosure Package, has been duly authorized,
executed and delivered by such applicable party and constitutes the valid agreement
thereof, enforceable in accordance with its terms, except as limited by bankruptcy
and general equitable principles and the execution, delivery and performance of any
of such agreements did not, at the time of execution and delivery, and does not
constitute a breach of, or default under, the charter or by-laws of such party or any
material contract, lease or other instrument to which such party is a party or by
which its properties may be bound or any law, administrative regulation or
administrative or court order or decree.
(viii) The Company, its subsidiaries and the Related Entities hold title to the
properties and assets described in the Prospectus and the General Disclosure Package,
subject only to the liens and encumbrances securing indebtedness reflected in the
Prospectus and the General Disclosure Package and such other liens, encumbrances and
matters of record which do not materially and adversely affect the value of such
properties and assets considered in the aggregate.
(ix) Each Significant Subsidiary of the Company has been duly incorporated and
is validly existing as a corporation in good standing under the laws of the
jurisdiction of its incorporation, has corporate power and authority to own, lease
and operate its properties and to conduct its business as described in the Prospectus
or the General Disclosure Package and, to the best of his knowledge and information,
is duly qualified as a foreign corporation to transact business and is in good
standing in each jurisdiction in which it owns or leases real property, except where
the failure to so qualify would not have a material adverse effect on the condition,
financial or otherwise, or on the earnings, business affairs or business prospects of
the Company and its subsidiaries considered as one enterprise; and all of the issued
and outstanding capital stock of each such Significant Subsidiary has been duly
authorized and validly issued, is fully paid and non-assessable and, to the best of
his knowledge and information, is owned by the Company, directly or through
subsidiaries, free and clear of any security interest, mortgage, pledge, lien,
encumbrance, claim or equity, except for security interests granted in respect of
indebtedness of the Company or any of its subsidiaries and described in the
Prospectus and the General Disclosure Package.
(4) The favorable opinion, dated as of the Closing Time, of Sidley Austin llp,
counsel for the Underwriters, in form and substance satisfactory to the Underwriters.
(5) In giving their opinions required by subsections (b)(1) and (b)(4), respectively,
of this Section 0, Xxxxxx & Xxxxxxx XXX xxx Xxxxxx Xxxxxx llp shall each
28
additionally state that nothing has come to their attention that would lead them to
believe that the Original Registration Statement or any amendment thereto (except for
financial statements and schedules and other financial data included or incorporated by
reference therein or omitted therefrom and the Form T-1, as to which they need make no
statement), at the time such Original Registration Statement or any such amendment became
effective, contained an untrue statement of a material fact or omitted to state a material
fact required to be stated therein or necessary to make the statements therein not
misleading; that the Registration Statement, including the Rule 430B Information (except for
financial statements and schedules and other financial data included or incorporated by
reference therein or omitted therefrom and the Form T-1, as to which they need make no
statement), at each deemed effective date with respect to the Underwriters pursuant to Rule
430B(f)(2) of the 1933 Act Regulations, contained an untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary to make the
statements therein not misleading; or that the Prospectus or any amendment or supplement
thereto (except for financial statements and schedules and other financial data included or
incorporated by reference therein or omitted therefrom and the Form T-1, as to which they
need make no statement), as of the date of the Prospectus, as of the date of any such
amended or supplemented prospectus and at the Closing Time, included or includes an untrue
statement of a material fact or omitted or omits to state a material fact necessary in order
to make the statements therein, in light of the circumstances under which they were made,
not misleading. In addition, nothing has come to their attention that would lead them to
believe that the General Disclosure Package, other than the financial statements and
schedules and other financial data included or incorporated by reference therein or omitted
therefrom, as to which they need make no statement, as of the Applicable Time, contained any
untrue statement of a material fact or omitted to state any material fact necessary in order
to make the statements therein, in the light of circumstances under which they were made,
not misleading. With respect to statements contained in the General Disclosure Package, any
statement contained in any of the constituent documents shall be deemed to be modified or
superseded to the extent that any information contained in subsequent constituent documents
modifies or replaces such statement.
(6) In giving their opinions, Xxxxxx & Xxxxxxx LLP, Xxxxxx X. Xxxxxxxx, Esq., or other
counsel satisfactory to the Underwriters, and Sidley Austin llp may rely, (1) as to
matters involving the laws of the State of Maryland upon the opinion of Xxxxxxx LLP (or
other counsel reasonably satisfactory to counsel for the Underwriters in form and substance
satisfactory to counsel for the Underwriters), (2) as to all matters of fact, upon
certificates and written statements of officers and employees of and accountants for the
Company, and (3) as to the qualification and good standing of the Company or any of its
subsidiaries to do business in any state or jurisdiction, upon certificates of appropriate
government officials or opinions of counsel in such jurisdictions.
(c) At Closing Time, there shall not have been, since the date of the applicable Terms
Agreement or since the respective dates as of which information is given in the Registration
Statement, the Prospectus or the General Disclosure Package, any material adverse change in the
condition, financial or otherwise, or in the earnings, business affairs or business prospects of
the Company and its subsidiaries considered as one enterprise, whether or not arising in the
ordinary
29
course of business; and you shall have received a certificate of the Chief Executive Officer,
the President or a Vice President of the Company and the chief financial officer or chief
accounting officer of the Company, dated as of such Closing Time, to the effect that (i) there has
been no such material adverse change and (ii) the representations and warranties in Section 1 are
true and correct with the same force and effect as though made on such Closing Time.
(d) At the time of execution of the applicable Terms Agreement, you shall have received from
PricewaterhouseCoopers LLP a letter dated such date, in form and substance satisfactory to you, to
the effect that (i) they are independent accountants with respect to the Company within the meaning
of the 1933 Act and the 1933 Act Regulations thereunder; (ii) it is their opinion that the
consolidated financial statements and financial statement schedules of the Company and the
historical summaries of revenue and certain operating expenses for the properties related thereto
included or incorporated by reference in the Registration Statement, the Prospectus or the General
Disclosure Package and audited by them and covered by their opinions therein comply as to form in
all material respects with the applicable accounting requirements of the 1933 Act and the 1933 Act
Regulations; (iii) they have performed limited procedures, not constituting an audit, including a
reading of the latest available unaudited interim consolidated financial statements of the Company,
a reading of the minute books of the Company, inquiries of certain officials of the Company who
have responsibility for financial and accounting matters and such other inquiries and procedures as
may be specified in such letter, and on the basis of such limited review and procedures nothing
came to their attention that caused them to believe that (A) any material modifications should be
made to the unaudited financial statements and financial statement schedules of the Company
included or incorporated by reference in the Registration Statement, the Prospectus or the General
Disclosure Package for them to be in conformity with generally accepted accounting principles, (B)
the unaudited financial statements and financial statement schedules of the Company included or
incorporated by reference in the Registration Statement, the Prospectus or the General Disclosure
Package do not comply as to form in all material respects with the applicable accounting
requirements of the 1934 Act as it relates to Form 10-Q and the 1934 Act Regulations, (C) the
unaudited operating data and balance sheet data of the Company in the Registration Statement, the
Prospectus or the General Disclosure Package under the caption “Selected Consolidated Financial
Data” were not determined on a basis substantially consistent with that used in determining the
corresponding amounts in the audited financial statements included or incorporated by reference in
the Registration Statement, the Prospectus or the General Disclosure Package, (D) the unaudited pro
forma condensed financial statements included in or incorporated by reference in the Company’s
Registration Statement, if any, do not comply as to form in all material respects with the
applicable accounting requirements of Rule 11-02 of Regulation S-X under the 1933 Act or that the
pro forma adjustments have not been properly applied to the historical amounts in the compilation
of such statements or (E) at a specified date not more than three business days prior to the date
of the applicable Terms Agreement, there has been any change in the capital stock of the Company or
in the consolidated long-term debt of the Company or any decrease in the net assets of the Company,
as compared with the amounts shown in the most recent consolidated balance sheet included or
incorporated by reference in the Registration Statement, the Prospectus or the General Disclosure
Package or, during the period from the date of the most recent consolidated statement of operations
included or incorporated by reference in the Registration Statement, the Prospectus or the General
Disclosure Package to a specified date not more than three business days prior to the date of the
applicable Terms Agreement, there were any
30
decreases, as compared with the corresponding period in the preceding year, in consolidated
revenues, or decrease in net income or net income per share of the Company, except in all instances
for changes, increases or decreases which the Registration Statement, the Prospectus and the
General Disclosure Package disclose have occurred or may occur; and (iv) in addition to the audit
referred to in their opinions and the limited procedures referred to in clause (iii) above, they
have carried out certain specified procedures, not constituting an audit, with respect to certain
amounts, percentages and financial information which are included or incorporated by reference in
the Registration Statement, the Prospectus or the General Disclosure Package and which are
specified by you, and have found such amounts, percentages and financial information to be in
agreement with the relevant accounting, financial and other records of the Company and its
subsidiaries identified in such letter.
(e) At Closing Time, you shall have received from PricewaterhouseCoopers LLP a letter dated as
of Closing Time to the effect that they reaffirm the statements made in the letter furnished
pursuant to subsection (d) of this Section, except that the “specified date” referred to shall be a
date not more than three business days prior to such Closing Time.
(f) At Closing Time, counsel for the Underwriters shall have been furnished with such
documents and opinions as they may reasonably require for the purpose of enabling them to pass upon
the issuance and sale of the Underwritten Securities as herein contemplated and related
proceedings, or in order to evidence the accuracy of any of the representations or warranties, or
the fulfillment of any of the conditions, herein contained; and all proceedings taken by the
Company in connection with the issuance and sale of the Underwritten Securities as herein
contemplated shall be satisfactory in form and substance to you and counsel for the Underwriters.
(g) In the event the Underwriters exercise their option provided in the applicable Terms
Agreement as set forth in Section 2(b) hereof to purchase all or any portion of the Option
Securities, the representations and warranties of the Company contained herein and the statements
in any certificates furnished by the Company hereunder shall be true and correct as of each Date of
Delivery, and, at the relevant Date of Delivery, you shall have received:
(1) A certificate, dated such Date of Delivery, of the Chief Executive Officer, the
President or a Vice President of the Company and the chief financial officer or chief
accounting officer of the Company, in their capacities as such, confirming that the
certificate delivered at Closing Time pursuant to Section 5(c) hereof remains true and
correct as of such Date of Delivery.
(2) The favorable opinion of Xxxxxx & Xxxxxxx LLP, counsel for the Company, in form and
substance satisfactory to counsel for the Underwriters, dated such Date of Delivery,
relating to the Option Securities and otherwise substantially to the same effect as the
opinion required by Sections 5(b)(1) and 5(b)(5) hereof.
(3) The favorable opinion of Xxxxxxx LLP, Maryland counsel to the Company, in form and
substance satisfactory to counsel for the Underwriters, dated such Date of Delivery,
relating to the Option Securities and otherwise substantially to the same effect as the
opinion required by Section 5(b)(2) hereof.
31
(4) The favorable opinion of Xxxxxx X. Xxxxxxxx, Esq., counsel for the Company, or
other counsel satisfactory to the Underwriters, in form and substance satisfactory to
counsel for the Underwriters, dated such Date of Delivery, relating to the Option Securities
and otherwise substantially to the same effect as the opinion required by Section 5(b)(3)
hereof.
(5) The favorable opinion of Sidley Austin llp, counsel for the Underwriters,
dated such Date of Delivery, relating to the Option Securities and otherwise to the same
effect as the opinion required by Sections 5(b)(4) and 5(b)(5) hereof.
(6) A letter from PricewaterhouseCoopers LLP, in form and substance satisfactory to you
and dated such Date of Delivery, substantially the same in scope and substance as the letter
furnished to you pursuant to Section 5(e) hereof, except that the “specified date” in the
letter furnished pursuant to this Section 5(g)(6) shall be a date not more than three
business days prior to such Date of Delivery.
If any condition specified in this Section 5 shall not have been fulfilled when and as
required to be fulfilled, the applicable Terms Agreement may be terminated by you by notice to the
Company at any time at or prior to the Closing Time, which notice shall be confirmed in writing by
the Underwriters as soon as reasonably practicable if so requested by the Company, and such
termination shall be without liability of any party to any other party except as provided in
Section 4 hereof and except that Sections 6, 7, 8 and 15 shall survive any such termination and
remain in full force and effect.
Section 6. Indemnification.
(a) The Company agrees to indemnify and hold harmless each Underwriter and each person, if
any, who controls any Underwriter within the meaning of Section 15 of the 1933 Act or Section 20 of
the 1934 Act as follows:
(1) against any and all loss, liability, claim, damage and expense whatsoever, as
incurred, arising out of any untrue statement or alleged untrue statement of a material fact
contained in the Registration Statement (or any amendment thereto), including the Rule 430B
Information, or the omission or alleged omission therefrom of a material fact required to be
stated therein or necessary to make the statements therein not misleading or arising out of
any untrue statement or alleged untrue statement of a material fact included in any
preliminary prospectus, any Issuer Free Writing Prospectus or the Prospectus (or any
amendment or supplement thereto), or the omission or alleged omission therefrom of a
material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading;
(2) against any and all loss, liability, claim, damage and expense whatsoever, as
incurred, to the extent of the aggregate amount paid in settlement of any litigation, or
investigation or proceeding by any governmental agency or body, commenced or threatened, or
of any claim whatsoever based upon any such untrue statement or omission referred to in
subsection (l) above, or any such alleged untrue statement or omission if any such
settlement is effected with the written consent of the Company;
32
(3) against any and all expense whatsoever (including the fees and disbursements
of counsel chosen by you), as incurred, which was reasonably incurred in investigating,
preparing or defending against any litigation, or any investigation or proceeding by any
governmental agency or body, commenced or threatened, or any claim whatsoever based upon any
such untrue statement or omission, or any such alleged untrue statement or omission, to the
extent that any such expense is not paid under (1) or (2) above;
provided, however, that this indemnity agreement shall not apply to any loss, liability,
claim, damage or expense to the extent arising out of any untrue statement or omission or alleged
untrue statement or omission made in reliance upon and in conformity with written information
furnished to the Company by any Underwriter through you expressly for use in the Registration
Statement (or any amendment thereto), including the Rule 430B Information, or any preliminary
prospectus, any Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement
thereto) or made in reliance upon the Trustee’s Statement of Eligibility filed as an exhibit to the
Registration Statement.
(b) Each Underwriter severally agrees to indemnify and hold harmless the Company, its
directors, each of its officers who signed the Registration Statement, and each person, if any, who
controls the Company within the meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act
against any and all loss, liability, claim, damage and expense described in the indemnity contained
in subsection (a) of this Section, but only with respect to untrue statements or omissions, or
alleged untrue statements or omissions, made in the Registration Statement (or any amendment
thereto), including the Rule 430B Information, or any preliminary prospectus, any Issuer Free
Writing Prospectus or the Prospectus (or any amendment or supplement thereto) in reliance upon and
in conformity with written information furnished to the Company by such Underwriter through you
expressly for use therein.
(c) Each indemnified party shall give notice as promptly as reasonably practicable to each
indemnifying party of any action commenced against it in respect of which indemnity may be sought
hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party
from any liability which it may have otherwise than on account of this indemnity agreement. An
indemnifying party may participate at its own expense in the defense of such action. If it so
elects within a reasonable time after receipt of such notice, an indemnifying party, jointly with
any other indemnifying parties receiving such notice, may assume the defense of such action with
counsel chosen by it and approved by the indemnified parties defendant in such action, unless such
indemnified parties reasonably object to such assumption on the ground that there may be legal
defenses available to them which are different from or in addition to those available to such
indemnifying party. If an indemnifying party assumes the defense of such action, the indemnifying
parties shall not be liable for any fees and expenses of counsel for the indemnified parties
incurred thereunder in connection with such action. In no event shall the indemnifying parties be
liable for fees and expenses of more than one counsel (in addition to any local counsel) separate
from their own counsel for all indemnified parties in connection with any one action or separate
but similar or related actions in the same jurisdiction arising out of the same general allegations
or circumstances. No indemnifying party shall, without the prior written consent of the indemnified
parties, settle or compromise or consent to the entry of any judgment with respect to any
litigation, or any
33
investigation or proceeding by any governmental agency or body, commenced or threatened, or
any claim whatsoever in respect of which indemnification or contribution could be sought under this
Section 6 or Section 7 hereof (whether or not the indemnified parties are actual or potential
parties thereto), unless such settlement, compromise or consent (i) includes an unconditional
release of each indemnified party from all liability arising out of such litigation, investigation,
proceeding or claim and (ii) does not include a statement as to or an admission of fault,
culpability or a failure to act by or on behalf of any indemnified party.
Section 7. Contribution. In order to provide for just and equitable contribution in
circumstances in which the indemnity agreement provided for in Section 6 is for any reason held to
be unenforceable by the indemnified parties although applicable in accordance with its terms, the
Company and the Underwriters with respect to the offering of the Underwritten Securities shall
contribute to the aggregate losses, liabilities, claims, damages and expenses of the nature
contemplated by said indemnity agreement incurred by the Company and one or more of the
Underwriters in respect of such offering, as incurred, in such proportions that the Underwriters
are responsible for that portion represented by the percentage that the underwriting discount
appearing on the cover page of the applicable prospectus supplement in respect of such offering
bears to the initial public offering price appearing thereon and the Company is responsible for the
balance; provided, however, that no person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the 0000 Xxx) shall be entitled to contribution from any person who was
not guilty of such fraudulent misrepresentation. Notwithstanding the provisions of this Section 7,
no Underwriter shall be required to contribute any amount in excess of the amount by which the
total price at which the Underwritten Securities purchased by it pursuant to the applicable Terms
Agreement and distributed to the public were offered to the public exceeds the amount of any
damages which such Underwriter has otherwise been required to pay in respect of such losses,
liabilities, claims, damages and expenses. The Underwriters’ obligation to contribute pursuant to
this Section 7 shall be several in proportion to their respective underwriting commitments and not
joint. For purposes of this Section 7, each person, if any, who controls an Underwriter within the
meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to
contribution as such Underwriter, and each director of the Company, each officer of the Company who
signed the Registration Statement, and each person, if any, who controls the Company within the
meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to
contribution as the Company.
Section 8. Representations, Warranties and Agreements to Survive Delivery. All
representations, warranties and agreements contained in this Agreement or the applicable Terms
Agreement, or contained in certificates of officers of the Company submitted pursuant hereto, shall
remain operative and in full force and effect, regardless of any termination of this Agreement or
the applicable Terms Agreement, or investigation made by or on behalf of any Underwriter or any
controlling person, or by or on behalf of the Company and shall survive delivery of and payment for
the Underwritten Securities.
Section 9. Termination of Agreement.
(a) This Agreement (excluding the applicable Terms Agreement) may be terminated for any reason
at any time by the Company or by you upon the giving of 30 days’ written notice of such termination
to the other party hereto.
34
(b) You may also terminate the applicable Terms Agreement, by notice to the Company, at any
time at or prior to the applicable Closing Time if (i) there has been, since the date of such Terms
Agreement or since the respective dates as of which information is given in the Registration
Statement, the Prospectus or the General Disclosure Package, any material adverse change in the
condition, financial or otherwise, or in the earnings, business affairs or business prospects of
the Company and its subsidiaries considered as one enterprise, whether or not arising in the
ordinary course of business, or (ii) there has occurred any material adverse change in the
financial markets in the United States or any outbreak or escalation of hostilities or other
national or international calamity or crisis, the effect of which is such as to make it, in your
judgment, impracticable or inadvisable to market the Underwritten Securities or enforce contracts
for the sale of the Underwritten Securities, or (iii) trading in any of the securities of the
Company has been suspended by the Commission or the New York Stock Exchange, or if trading
generally on either the New York Stock Exchange or the American Stock Exchange or in the Nasdaq
Stock Market has been suspended, or minimum or maximum prices for trading have been fixed, or
maximum ranges for prices have been required, by any of said exchanges or by such system or by
order of the Commission, the National Association of Securities Dealers, Inc. or any other
governmental authority, or a general banking moratorium has been declared by Federal, New York or
Maryland authorities, or (iv) there has occurred a material disruption in securities settlement or
clearance services, or (v) the rating assigned by any nationally recognized statistical rating
organization to any long-term debt securities of the Company as of the date of the applicable Terms
Agreement shall have been lowered or withdrawn since such date or if any such rating organization
shall have publicly announced that it has any long-term debt securities of the Company under
surveillance or review.
(c) In the event of any such termination, (x) the covenants set forth in Section 3 with
respect to any offering of Underwritten Securities shall remain in effect so long as any
Underwriter owns any such Underwritten Securities purchased from the Company pursuant to the
applicable Terms Agreement and (y) the covenant set forth in Section 3(g) hereof, the provisions of
Section 4 hereof, the indemnity and contribution agreements set forth in Sections 6 and 7 hereof,
and the provisions of Sections 8 and 15 hereof shall survive such termination and remain in full
force and effect.
Section 10. Default by One or More of the Underwriters. If one or more of the
Underwriters shall fail at the applicable Closing Time to purchase the Underwritten Securities
which it or they are obligated to purchase under the applicable Terms Agreement (the “Defaulted
Securities”), then you shall have the right, within 24 hours thereafter, to make arrangements for
one or more of the non-defaulting Underwriters, or any other underwriters, to purchase all, but not
less than all, of the Defaulted Securities in such amounts as may be agreed upon and upon the terms
herein set forth; if, however, you shall not have completed such arrangements within such 24-hour
period, then:
(a) if the aggregate principal amount of Defaulted Securities does not exceed 10% of the
aggregate principal amount of Underwritten Securities to be purchased pursuant to such Terms
Agreement, the non-defaulting Underwriters named in such Terms Agreement shall be obligated,
severally and not jointly, to purchase the full amount thereof in the proportions that their
respective underwriting obligations hereunder bear to the underwriting obligations of all
non-defaulting Underwriters, or
35
(b) if the aggregate principal amount of Defaulted Securities exceeds 10% of the aggregate
principal amount of Underwritten Securities to be purchased pursuant to such Terms Agreement, the
applicable Terms Agreement shall terminate without liability on the part of any non-defaulting
Underwriter.
No action taken pursuant to this Section shall relieve any defaulting Underwriter from
liability in respect of its default under this Agreement and the applicable Terms Agreement.
In the event of any such default which does not result in a termination of the applicable
Terms Agreement, either you or the Company shall have the right to postpone the applicable Closing
Time for a period not exceeding seven days in order to effect any required changes in the
Registration Statement or the Prospectus or in any other documents or arrangements. As used herein,
the term “Underwriter” includes any person substituted for an Underwriter under this Section 10.
Section 11. Intentionally Omitted.
Section 12. Notices. All notices and other communications hereunder shall be in
writing and shall be deemed to have been duly given if mailed or transmitted by any standard form
of telecommunication. Notices to the Underwriters shall be directed as follows: c/o Banc of
America Securities LLC, 00 Xxxx 00xx Xxxxxx, XX0-000-00-00, Xxx Xxxx, Xxx Xxxx 00000,
Attention: High Grade Transaction Management/Legal, Facsimile: (000) 000-0000). Notices to the
Company shall be directed to it at 3333 New Hyde Park Road, Suite 100, New Hyde Park, New York,
11042-0020, attention of Xxxxxx Xxxxxx, Chairman of the Board.
Section 13. No Advisory or Fiduciary Relationship. The Company acknowledges and
agrees that: (i) the purchase and sale of the Underwritten Securities pursuant to the applicable
Terms Agreement and this Agreement, including the determination of the price for the Underwritten
Securities and any related discounts and commissions, is an arm’s-length commercial transaction
between the Company, on the one hand, and the Underwriter or several Underwriters, on the other
hand; (ii) in connection with each transaction contemplated by this Agreement and the applicable
Terms Agreement and the process leading to such transaction, each Underwriter is acting solely as a
principal and not as the agent or fiduciary of the Company or any of its affiliates; (iii) no
Underwriter has assumed any advisory or fiduciary responsibility in favor of the Company or any of
its affiliates with respect to any of the transactions contemplated by this Agreement and the
applicable Terms Agreement or the process leading thereto (irrespective of whether such Underwriter
has advised or is currently advising the Company or any of its affiliates on other matters) and no
Underwriter has any obligation to the Company or any of its affiliates with respect to any offering
of Underwritten Securities except the obligations expressly set forth in this Agreement and the
applicable Terms Agreement; (iv) each Underwriter and its affiliates may be engaged in a broad
range of transactions that involve interests that differ from those of the Company; and (v) no
Underwriter has provided any legal, accounting, regulatory or tax advice with respect to the
transactions contemplated by this Agreement and the applicable Terms Agreement, and the Company has
consulted its own legal and financial advisors to the extent it deemed appropriate.
36
This Agreement and the applicable Terms Agreement supersede all prior agreements and
understandings (whether written or oral) between the Company and the Underwriter or several
Underwriters, or any of them, with respect to the subject matter hereof and thereof. The Company
hereby waives and releases, to the fullest extent permitted by law, any claims that the Company may
have against the Underwriter or several Underwriters with respect to any breach or alleged breach
of agency or fiduciary duty.
Section 14. Parties. This Agreement and the applicable Terms Agreement shall inure
to the benefit of and be binding upon you and the Company and any Underwriter who becomes a party
to such Terms Agreement, and their respective successors. Nothing expressed or mentioned in this
Agreement or the applicable Terms Agreement is intended or shall be construed to give any person,
firm or corporation, other than those referred to in Sections 6 and 7 and their heirs and legal
representatives, any legal or equitable right, remedy or claim under or in respect of this
Agreement or such Terms Agreement or any provision herein or therein contained. This Agreement and
the applicable Terms Agreement and all conditions and provisions hereof and thereof are intended to
be for the sole and exclusive benefit of the parties hereto and thereto and their respective
successors and said controlling persons and officers and directors and their heirs and legal
representatives, and for the benefit of no other person, firm or corporation. No purchaser of
Underwritten Securities from any Underwriter shall be deemed to be a successor by reason merely of
such purchase.
Section 15. Governing Law and Time. This Agreement and the applicable Terms
Agreement shall be governed by and construed in accordance with the laws of the State of New York
applicable to agreements made and to be performed in said State. Specified times of day refer to
New York City time.
Section 16. Counterparts. This Agreement and the applicable Terms Agreement may be
executed in one or more counterparts, and if executed in more than one counterpart the executed
counterparts shall constitute a single instrument.
37
If the foregoing is in accordance with your understanding of our agreement, please sign and
return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts,
will become a binding agreement between you and the Company in accordance with its terms.
Very truly yours, Kimco Realty Corporation |
||||
By: | /s/ Xxxxx X. Xxxxx | |||
Name: Xxxxx X. Xxxxx Title: Vice President — Treasurer |
||||
Confirmed and Accepted,
as of the date first above written:
as of the date first above written:
BANC OF AMERICA SECURITIES LLC
CITIGROUP GLOBAL MARKETS INC.
X.X. XXXXXX SECURITIES INC.
UBS SECURITIES LLC
CITIGROUP GLOBAL MARKETS INC.
X.X. XXXXXX SECURITIES INC.
UBS SECURITIES LLC
By: Banc of America Securities LLC
By: | /s/ Xxxxx X. Xxxxxxx | |||
Name: | Xxxxx X. Xxxxxxx | |||
Title: | Vice President | |||
Acting on behalf of itself and as representative of
the other named Underwriters.
the other named Underwriters.
38
Exhibit A
KIMCO REALTY CORPORATION
(a Maryland corporation)
(a Maryland corporation)
[Title of Securities]
TERMS AGREEMENT
Dated:
To:
|
Kimco Realty Corporation | |
0000 Xxx Xxxx Xxxx Xxxx | ||
Xxxxx 000 | ||
New Hyde Park, New York 11042-0020 |
Attention:
|
Chairman of the | |
Board of Directors |
Ladies and Gentlemen:
We (the “Representative”) understand that Kimco Realty Corporation, a Maryland corporation
(the “Company”), proposes to issue and sell $ aggregate principal amount of its [Title of Debt
Securities] (the “Underwritten Securities”). Subject to the terms and conditions set forth or
incorporated by reference herein, the underwriters named below (the “Underwriters”) offer to
purchase, severally and not jointly, the respective amount of Underwritten Securities set forth
below opposite their respective names, and a proportionate share of Option Securities (as defined
in the Underwriting Agreement referred to below) to the extent any are purchased, at the purchase
price set forth below.
Principal Amount | ||||
of | ||||
Underwriter | Underwritten Securities | |||
Total |
||||
$ | ||||
A-1
The Underwritten Securities shall have the following terms:
Title of Securities:
Currency:
Principal amount to be issued:
Current ratings:
Xxxxx’x Investors Service, Inc. -
Standard & Poor’s Ratings Services -
Interest rate or formula:
Interest payment dates:
Stated maturity date:
Redemption and/or repayment provisions:
Sinking fund requirements:
Number of Option Securities, if any:
Delayed Delivery Contracts: [authorized] [not authorized]
[Date of delivery:
Minimum contract:
Maximum aggregate principal amount:
Fee: %]
Currency:
Principal amount to be issued:
Current ratings:
Xxxxx’x Investors Service, Inc. -
Standard & Poor’s Ratings Services -
Interest rate or formula:
Interest payment dates:
Stated maturity date:
Redemption and/or repayment provisions:
Sinking fund requirements:
Number of Option Securities, if any:
Delayed Delivery Contracts: [authorized] [not authorized]
[Date of delivery:
Minimum contract:
Maximum aggregate principal amount:
Fee: %]
Method of Offering: | Fixed Price: % of principal amount plus accrued interest, if any, or amortized original issue discount, if any, from , 200 . |
Variable Price |
Purchase price: % of principal amount (payable in [same] [next] day funds).
Conversion provisions:
Form:
Issuer General Use Free Writing Prospectus (including the Final Term Sheet, if applicable): See
Schedule A hereto.
Applicable Time:
Other terms:
Closing time, date and location:
Conversion provisions:
Form:
Issuer General Use Free Writing Prospectus (including the Final Term Sheet, if applicable): See
Schedule A hereto.
Applicable Time:
Other terms:
Closing time, date and location:
All of the provisions contained in the Underwriting Agreement attached as Annex A hereto are
hereby incorporated by reference in their entirety herein and shall be deemed to be a part of this
Terms Agreement to the same extent as if such provisions had been set forth in full herein. Terms
defined in such document are used herein as therein defined.
A-2
Please accept this offer no later than o’clock P.M. (New York City time) on by
signing a copy of this Terms Agreement in the space set forth below and returning the signed copy
to us.
Very truly yours,
BANC OF AMERICA SECURITIES LLC
CITIGROUP GLOBAL MARKETS INC.
X.X. XXXXXX SECURITIES INC.
UBS SECURITIES LLC
CITIGROUP GLOBAL MARKETS INC.
X.X. XXXXXX SECURITIES INC.
UBS SECURITIES LLC
By: Banc of America Securities LLC
By: | ||||
Name: | Xxxxx X. Xxxxxxx | |||
Title: | Vice President | |||
Acting on behalf of itself and as representative of
the other named Underwriters.
the other named Underwriters.
Accepted:
KIMCO REALTY CORPORATION |
||||
By: | ||||
Name: | ||||
Title: |
A-3
Schedule A
to Terms Agreement
to Terms Agreement
[Attach Issuer Free Writing Prospectus(es)]
A-4
Exhibit B
KIMCO REALTY CORPORATION
(a Maryland corporation)
(a Maryland corporation)
[Title of Securities]
DELAYED DELIVERY CONTRACT
Dated: , 20
Attention:
|
Chairman of the | |
Board of Directors |
Ladies and Gentlemen:
The undersigned hereby agrees to purchase from Kimco Realty Corporation (the “Company”), and
the Company agrees to sell to the undersigned on , 20 (the “Delivery Date”), principal amount of
the Company’s [insert title of security] (the “Securities”), offered by the Company’s Prospectus
dated , 20 , as supplemented by its Prospectus Supplement dated , 20 , receipt of which is hereby
acknowledged at a purchase price of % of the principal amount thereof, plus accrued interest
from , 20 , to the Delivery Date, and on the further terms and conditions set forth in this
contract.
Payment for the Securities which the undersigned has agreed to purchase on the Delivery Date
shall be made to the Company or its order by certified or official bank check in New York Clearing
House funds at the office of , on the Delivery Date, upon delivery to the undersigned of the
Securities to be purchased by the undersigned in definitive form and in such denominations and
registered in such names as the undersigned may designate by written or telegraphic communication
addressed to the Company not less than five full business days prior to the Delivery Date.
The obligation of the undersigned to take delivery of and make payment for Securities on the
Delivery Date shall be subject only to the conditions that (1) the purchase of Securities to be
made by the undersigned shall not on the Delivery Date be prohibited under the laws of the
jurisdiction to which the undersigned is subject and (2) the Company, on or before , 20 , shall
have sold to the Underwriters of the Securities (the “Underwriters”) such principal amount of the
Securities as is to be sold to them pursuant to the Terms Agreement dated , 20 , between the
Company and the Underwriters. The obligation of
B-1
the undersigned to take delivery of and make payment for Securities shall not be affected by
the failure of any purchaser to take delivery of and make payments for Securities pursuant to other
contracts similar to this contract. The undersigned represents and warrants to you that its
investment in the Securities is not, as of the date hereof, prohibited under the laws of any
jurisdiction to which the undersigned is subject and which govern such investment.
Promptly after completion of the sale to the Underwriters, the Company will mail or deliver to
the undersigned at its address set forth below notice to such effect, accompanied by a copy of the
opinion of counsel for the Company delivered to the Underwriters in connection therewith.
By the execution hereof, the undersigned represents and warrants to the Company that all
necessary corporate action for the due execution and delivery of this contract and the payment for
and purchase of the Securities has been taken by it and no further authorization or approval of any
governmental or other regulatory authority is required for such execution, delivery, payment or
purchase, and that, upon acceptance hereof by the Company and mailing or delivery of a copy as
provided below, this contract will constitute a valid and binding agreement of the undersigned in
accordance with its terms.
This contract will inure to the benefit of and be binding upon the parties hereto and their
respective successors, but will not be assignable by either party hereto without the written
consent of the other.
It is understood that the Company will not accept Delayed Delivery Contracts for an aggregate
principal amount of Securities in excess of $ and that the acceptance of any Delayed Delivery
Contract is in the Company’s sole discretion and, without limiting the foregoing, need not be on a
first-come, first-served basis. If this contract is acceptable to the Company, it is requested that
the Company sign the form of acceptance on a copy hereof and mail or deliver a signed copy hereof
to the undersigned at its address set forth below. This will become a binding contract between the
Company and the undersigned when such copy is so mailed or delivered.
B-2
This Agreement shall be governed by the laws of the State of New York applicable to agreements
made and to be performed in such State.
Yours very truly, |
||||||
(Name of Purchaser) | ||||||
By: | ||||||
Accepted as of the date
first above written.
first above written.
KIMCO REALTY CORPORATION |
||||
By: | ||||
(Title) | ||||
PURCHASER—PLEASE COMPLETE AT TIME OF SIGNING
The name and telephone number of the representative of the Purchaser with whom details of
delivery on the Delivery Date may be discussed are as follows: (Please type or print.)
Telephone No. | ||||
(including | ||||
Name | Area Code) | |||
B-3